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Abstract Manipulation of neurotrophin (NT) signalling by
administration or depletion of NTs, by transgenic over-
expression or by deletion of genes coding for NTs and their
receptors has demonstrated the importance of NT signalling
for the survival and differentiation of neurons in sympa-
thetic and dorsal root ganglia (DRG). Combination with
mutation of the proapoptotic Bax gene allows the separa-
tion of survival and differentiation effects. These studies
together with cell culture analysis suggest that NT
signalling directly regulates the differentiation of neuron
subpopulations and their integration into neural networks.
The high-affinity NT receptors trkA, trkB and trkC are
restricted to subpopulations of mature neurons, whereas
their expression at early developmental stages largely
overlaps. trkC is expressed throughout sympathetic ganglia
and DRG early after ganglion formation but becomes
restricted to small neuron subpopulations during embryo-
genesis when trkA is turned on. The temporal relationship
between trkA and trkC expression is conserved between
sympathetic ganglia and DRG. In DRG, NGF signalling is
required not only for survival, but also for the differenti-
ation of nociceptors. Expression of neuropeptides calcitonin
gene-related peptide and substance P, which specify
peptidergic nociceptors, depends on nerve growth factor
(NGF) signalling. ret expression indicative of non-
peptidergic nociceptors is also promoted by the NGF-
signalling pathway. Regulation of TRP channels by NGF
signalling might specify the temperature sensitivity of
afferent neurons embryonically. The manipulation of NGF
levels “tunes” heat sensitivity in nociceptors at postnatal
and adult stages. Brain-derived neurotrophic factor signal-
ling is required for subpopulations of DRG neurons that are
not fully characterized; it affects mechanical sensitivity in
slowly adapting, low-threshold mechanoreceptors and
might involve the regulation of DEG/ENaC ion channels.
NT3 signalling is required for the generation and survival
of various DRG neuron classes, in particular propriocep-
tors. Its importance for peripheral projections and central
connectivity of proprioceptors demonstrates the signifi-
cance of NT signalling for integrating responsive neurons in
neural networks. The molecular targets of NT3 signalling in
proprioceptor differentiation remain to be characterized.
In sympathetic ganglia, NGF signalling regulates dendritic
development and axonal projections. Its role in the
specification of other neuronal properties is less well
analysed. In vitro analysis suggests the involvement of
NT signalling in the choice between the noradrenergic and
cholinergic transmitter phenotype, in the expression of
various classes of ion channels and for target connectivity.
In vivo analysis is required to show the degree to which NT
signalling regulates these sympathetic neuron properties in
developing embryos and postnatally.
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PGP9.5 neuron-specific protein gene product 9.5
PPT preprotachykinin
ret “rearranged during transfection” proto-oncogene
RT-
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polymerase chain reaction on template
synthesized by reverse transcription
SAM slowly adapting mechanoreceptor






trk tyrosine kinase receptor, high-affinity
neurotrophin receptor
TRP transient receptor potential family of cation
channels
VAChT vesicular acetylcholine transporter
VIP vasoactive intestinal peptide
Introduction
In 1951, a mouse sarcoma was reported that massively
affects development of the peripheral nervous system when
implanted in chick embryos (Levi-Montalcini and
Hamburger 1951). This observation initiated a research
effort that has demonstrated the involvement of nerve
growth factor (NGF), the neurotrophic activity produced by
the mouse sarcoma, and the other members of the neuro-
trophin (NT) family in the development of various
populations of peripheral autonomic and sensory neurons.
NGF administration and depletion studies in vivo have
uncovered profound effects on the survival of neurons from
dorsal root ganglia (DRG) and sympathetic ganglia (for a
review, see Johnson et al. 1986), a function confirmed and
extended to the related NTs, viz. brain-derived neurotrophic
factor (BDNF) and NT3, by analysis in mutant mice (for a
review, see Snider 1994). In addition to the survival effects
of NTs, other aspects of neuronal development are affected
by these growth factors. The promotion of neurite out-
growth may be the most prominent of these actions. In
addition, the regulation of functional properties in various
neuron populations became apparent when the hyperalgesic
effect of NGF administration with a concomitant alteration
in the sensitivity of certain DRG neuron populations
(Lewin et al. 1993; Lewin and Mendell 1994) and the
NGF-induced regulation of tyrosine hydroxylase (TH) and
dopamine β-hydroxylase (DBH) activity in sympathetic
neurons (Thoenen et al. 1971; Angeletti et al. 1972) were
observed in postnatal rats. The analysis of the differentia-
tion effects of NTs has been compromised, however, by
their requirement for neuron survival, in particular at
embryonic stages, when function-specifying genes become
expressed in specific populations of sensory and sympa-
thetic neurons (see below; for a review, see Ernsberger
2008). Combining mutation of the proapoptotic Bax gene
(for bcl-2 associated pro-apoptotic protein) with the
mutational inactivation of NT or of NT receptor genes,
however, prevents the loss of these neurons by cell death
and allows the analysis of the differentiation effects exerted
by NTs on these neuron populations during embryogenesis
(Patel et al. 2000, 2003; Luo et al. 2007). In combination
with cell culture analysis, the double-mutant analysis
indicates that NT signalling directly regulates the specifi-
cation of peripheral neuronal subtypes.
In this review, I shall discuss the effects elicited by the
manipulation of NT signalling in vivo via the administra-
tion and the antibody-mediated depletion of NTs and via
the mutation of the genes coding for NTs and their high-
affinity tyrosine kinase receptors (trkA, trkB and trkC). In
addition, the relevant tissue culture experiments are
considered, as they demonstrate whether NTs directly affect
DRG and sympathetic ganglion cells instead of promoting
neurite outgrowth and access to other growth factors.
Developmental expression of genes specifying neuronal
diversity
Neuronal genes in sympathetic and DRG become expressed
during embryonic development and the equipment of the
different neuron populations with population-specific gene
products commences during the second embryonic week to
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become refined to neuron subpopulations in the third
embryonic week of chick, rat and mouse development (for
a review, see Ernsberger 2008). Genes might be expressed
initially throughout the ganglion to become confined to
defined subpopulations with ongoing development by the
“progressive restriction” of expression, such as genes from
the cholinergic gene locus in sympathetic ganglia (for a
review, see Ernsberger 2008). Alternatively, they might
become detectable in an increasing number of neurons
because of a “progressive increase” in expression, such as
the genes encoding the neuropeptides calcitonin gene-
related peptide (CGRP) and substance P (SP) in DRG
neurons (see below). In both cases, a population-restricted
expression pattern is achieved during embryogenesis; this
pattern for the neuropeptides, but not for the cholinergic
locus, appears to be the mature pattern. Both expression
modes are observed for the developmental expression
profile of high-affinity NT receptors as detailed below.
High-affinity NT receptors
trkA and trkC, the high-affinity receptors for NGF and NT-
3, respectively (for reviews, see Klein 1994; Dechant et al.
1994; Barbacid 1994), show a developmental expression
profile with remarkable similarities between sympathetic
and DRG. Whereas trkC appears to be expressed through-
out the ganglia at early developmental stages and becomes
downregulated in a progressive restriction mode to a small
neuron population at birth, trkA is initially undetectable and
then becomes upregulated in a progressive increased mode
of expression in the vast majority (DRG) or apparently all
(sympathetic ganglia) neurons. For trkB, the high-affinity
receptor for BDNF, its expression in DRG and sympathetic
ganglia appears restricted from the outset.
trkA and trkC NT receptors are prominently expressed
during sympathetic neuron development
In situ hybridization (ISH) in adult rat shows that neurons
in both prevertebral and paravertebral sympathetic ganglia
express predominantly trkA mRNA (Wetmore and Olson
1995; Schmidt et al. 1998). All neurons in rat superior
cervical ganglia (SCG) strongly express trkA and 14%
express trkC mRNA (Wetmore and Olson 1995; Table 1).
Likewise, in adult human paravertebral sympathetic gan-
glia, all sympathetic neurons are reported to display trkA
immunoreactivity, with 10% being immunoreactive for trkC
(Garcia-Suarez et al. 1996). The observation of strong trkC
immunoreactivity in the majority of sympathetic neurons of
neonatal and adult rats (Zhou et al. 1997) is at variance with
mRNA expression data in rat and mice and immunohisto-
chemical analysis in humans and thus needs further
examination. No immunoreactivity has been revealed for
trkB in human ganglia (Garcia-Suarez et al. 1996) and a
few (<5%) of the neurons in rat SCG express trkB mRNA
but at low levels (Wetmore and Olson 1995).
trkC expression precedes trkA in rodent sympathetic
ganglia
Expression of trkA and trkC during sympathetic ganglion
development was initially studied in rat embryos (Ernfors et
al. 1992; Birren et al. 1993; DiCicco-Bloom et al. 1993).
Early expression of trkC is found at embryonic day 13
(E13) by ISH as low and diffuse labelling (Ernfors et al.
1992). During the following few days, trkC mRNA can be
detected by ISH (Ernfors et al. 1992; Birren et al. 1993) and
Northern blot (DiCicco-Bloom et al. 1993). After E17.5,
trkC mRNA decreases sharply (Birren et al. 1993) such that
expression at birth is reduced by an order of magnitude
(DiCicco-Bloom et al. 1993). Inversely, trkA is not
detectable at E13 (Ernfors et al. 1992) or E14.5 (Birren et
al. 1993) by ISH. At E16, however, most cells express low
levels of trkA mRNA and intense labelling is detected at
E18 (Ernfors et al. 1992). Northern blot analysis shows a
40-fold increase in trkA levels between E15.5 and birth
(DiCicco-Bloom et al. 1993). A further increase in trkA
levels occurring in rats postnatally has been detected with
polymerase chain reaction on template synthesized by
reverse transcription (RT-PCR; Ehrhard and Otten 1994).
In mouse, trkA transcripts in developing SCG are first
detected at E13.5 by ISH (Fagan et al. 1996). Expression
levels are increased at E15.5 and strong expression is
detectable in newborn animals. trkC transcripts are detected
as early as E11.5 in the sympathetic chain. At E13.5, they
can be observed throughout the newly formed SCG (Fagan et
al. 1996). With ongoing embryonic development, trkC
expression levels decrease and become restricted to a small
number of cells at postnatal day 0 (P0). Most of the
transcripts are reported to correspond to signalling isoforms
Species Method Percentage of positive cells Reference
trkA trkB trkC
Rat ISH 97 <5 19 Wetmore and Olson 1995
Human IHC all None 10 Garcia-Suarez et al. 1996
Table 1 trk expression in adult
mammalian sympathetic ganglia
(IHC immunohistochemistry,
ISH in situ hybridization)
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carrying the tyrosine kinase domain. By quantitative RT-
PCR, a decrease of mRNA levels by an order of magnitude is
observed for the kinase-positive trkC isoform relative to D-
glyceraldehyde-3-phosphate dehydrogenase in mouse SCG
between E14 and E18 (Wyatt et al. 1999; Fig. 1). Moreover,
mRNA levels for the kinase-negative trkC isoform are
reduced by ~70% during this time period (Wyatt et al.
1997), a decrease that is not NT3-dependent as it also occurs
in NT3 mutant animals (Wyatt et al. 1999). Likewise trkA
induction is NT3-independent as it occurs in NT3 mutants
(Wyatt et al. 1997) and trkC mutants (Fagan et al. 1996).
Expression of trkB is observed in embryonic sympathet-
ic ganglia (Schecterson and Bothwell 1992). By E13 and
E15, trkB-immunoreactive cells are detected coexpressing
TH in mouse lumbar sympathetic ganglia (Straub et al.
2007). In 3-day-old to 4-week-old rats, trkB mRNA is
barely detectable by RNA protection analysis in SCG,
although it occurs at low but distinct levels in prevertebral
ganglia (Dixon and McKinnon 1994).
Thus, detectable trkC expression precedes that of trkA
and is observed at E13 in rats and E11 in mice. Until birth,
trkC expression is strongly downregulated such that small
subpopulations are positive in postnatal mice, adult rats and
humans. trkA is detectable at E16 in rats and E13 in mice
and is expressed in the vast majority, or even in all neurons,
during late embryogenesis and after birth. trkB expression
during development has not been reported in detail.
trkC expression precedes trkA in avian sympathetic ganglia
trkC mRNA, as analysed by ISH, is detectable in primary
sympathetic ganglia of the chick embryo at E4–E5 (Kahane
and Kalcheim 1994). By E8, immunoreactivity is down-
regulated (Straub et al. 2007) and ISH staining of sections
Fig. 1 Development of neuron number and trk expression in the
superior cervical ganglion (SCG) of mouse embryos. a–c Number of
neurons (a), mitotic profiles (b) and pycnotic profiles (c) in mouse
SCG from embryonic day 11.5 (E11.5) to birth (P0/1). Data from
ElShamy et al. 1996 (red bars), Fagan et al. 1996 (yellow bars), Wyatt
et al. 1997 (white bars) and Francis et al. 1999 (blue bars). d Number
of neurons (red), TUNEL-positive profiles (green) and BrdU-
incorporating profiles (blue) in mouse SCG; from ElShamy et al.
1996. e, f Amount of mRNA for trkA (white bars) and the kinase-
negative trkC isoform (black bars in e) and the kinase-positive trkC
isoform (f) relative to D-glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA. Data from Wyatt et al. 1997, 1999
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from secondary sympathetic ganglia is faint (Kahane and
Kalcheim 1994), although the RT-PCR signal remains
detectable, as shown in quail (Zhang et al. 1994). In
contrast, trkA is readily detectable at E8 and, at E10, all
neurons appear trkA-immunoreactive. trkB-expressing cells
are not found by ISH between E4 and E14 (Dechant et al.
1993). trkB immunoreactivity, however, is observed tran-
siently in embryonic sympathetic ganglia, being first
detected at E5 and lost at E8 (Straub et al. 2007). At this
stage, a larger fraction of neurons appears trkB-positive
than trkA-positive and both coexpress trkC.
Thus, in chick sympathetic ganglia, trkC expression
appears to precede trkA expression and becomes down-
regulated with ongoing development. trkA colocalizes with
trkC during early stages of trkA expression and is
detectable throughout the ganglion at later stages. Immu-
nohistochemical data suggest early transient trkB expres-
sion in a large fraction of neurons also colocalizing with
trkC. The discrepancy with ISH data for trkB needs
clarification.
trkA and trkC expression patterns in sympathetic ganglia
of chick embryos correlate with noradrenergic
and cholinergic transmitter phenoptypes, respectively
In the paravertebral sympathetic ganglia of the chick embryo,
the NT receptors trkA and trkC show inverse expression
patterns (Brodski et al. 2002). At E12, the expression level
for both receptors, as analysed by ISH, varies considerably
between cells; cells expressing high levels for the mRNA of
one receptor show low levels for that of the other. In
addition, strong trkA expression overlaps with the noradren-
alin transporter (NET), a marker for the noradrenergic
transmitter phenotype. At E16, trkC immunoreactivity is
absent from domains expressing the noradrenergic marker
TH but is located in domains expressing the cholinergic
marker choline acetyltransferase (ChAT; Brodski et al. 2000).
At E18, trkA expression almost perfectly colocalizes with
NET expression and negatively correlates with ChAT, as
analysed by ISH (Brodski et al. 2002). Instead, ChAT
expression colocalizes with trkC.
Data on the possible correlation of trkC expression with
cholinergic properties in sympathetic ganglia of rodents are
not available.
High-affinity NT receptors trkA, trkB and trkC are
expressed in subpopulations of DRG neurons
Expression patterns for the high-affinity NT receptors of the
trk family show restriction to distinct DRG neuron
subpopulations in mature animals. In adult rodents and
humans, approximately 40% of DRG neurons express trkA,
the high-affinity NGF receptor (Table 2). Preferentially,
small neurons are trkA-positive (Mu et al. 1993; McMahon
et al. 1994) and 92% of these cells coexpress CGRP in rat
(Averill et al. 1995) indicating the nociceptive nature of this
neuron subpopulation. Smaller populations, constituting
approximately 20% of DRG neurons, express trkB and
trkC, the high-affinity receptors for BDNF and NT3,
respectively. Interestingly, the sum of trk-expressing neu-
rons does not account for all DRG neurons in adult rodents;
this is explained by a downregulation of trkA expression
and replacement by c-ret expression in a subpopulation of
the cells (see below).
trkA is expressed in 80% of mouse DRG neurons during
the third embryonic week and their proportion drops
to 40% postnatally
The developmental expression profile has been studied in
detail for trkA in rodents (Fig. 2, Tables 2, 3). Detection of
mRNA and protein by ISH and immunohistochemistry
Species, developmental stage Method Percentage of positive cells Reference
trkA trkB trkC
Development
Mouse, E11 IHC 20 40 70 Farinas et al. 1998
Mouse, E13 IHC 80 8 <10 Farinas et al. 1998
Mouse, P0.5 ISH 90 8 28/8 Liebl et al. 1997, 2000
Adult mammals
Mouse IHC 41 − 9 Orozco et al. 2001
Rat IHC 35–40 5 15–20 Kashiba et al. 1996
Rat ISH 36 9 19 Kashiba et al. 2003
Rat ISH 45 12 28 Kobayashi et al. 2005
Rat ISH 45 26 21 Wetmore and Olson 1995
Human ISH 46 29 24 Josephson et al. 2001
Table 2 trk expression in mam-
malian DRG (IHC immunohis-
tochemistry, ISH in situ
hybridization)
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(IHC) indicate an onset of expression in cervical and lumbar
DRG of mouse embryos at E10.5 when expression levels are
low and only a few positive cells are detectable (Phillips and
Armanini 1996; White et al. 1996). A rapid increase in the
number of trkA-positive cells occurs thereafter. As early as
E11, ~20% of L1 DRG neurons express trkA immunoreac-
tivity and their number increases dramatically over the next
two days (Farinas et al. 1998). trkA-immunoreactive cells do
not incorporate BrdU, have neuronal bipolar morphology
and are immunoreactive for the neurofilament 150-kDa
subunit indicating that neurons, but not precursors, express
the high-affinity NGF receptor (Farinas et al. 1998; White et
al. 1996). Moreover, in chick embryos, no dividing cells are
trkA-immunoreactive (Rifkin et al. 2000).
In mouse embryos, trkA-mRNA-positive cells amount to
more than 50% of lumbar DRG cells at E11.5 (White et al.
1996). At E13, 80% of DRG neurons are trkA-positive
(Farinas et al. 1998) and the same number is reported at E15
(White et al. 1996; Molliver and Snider 1997; Molliver et al.
1997). mRNA expression studies in rat embryos provide
similar results (Ernfors et al. 1992; but see Mu et al. 1993)
and protein detection describes the same 80% of neurons
expressing trkA during the third week of rat embryonic
development as analysed by IHC in L4/5 DRG (Benn et al.
2001). This high percentage of positive cells can still be
detected in neonatal rats and mice (Table 3). Immunohisto-
chemical studies in both species agree well thereby indicat-
ing a decrease in the proportion of trkA-positive cells to 60%
of DRG neurons at P7 (Bennett et al. 1996a; Molliver and
Snider 1997; Benn et al. 2001). Analysis in rat shows that
adult percentages of trkA-immunoreactive cells of approxi-
mately 40% are reached during the third postnatal week. In
mice, this value is reached as early as the second postnatal
week (Luo et al. 2007).
Fig. 2 Development of neuron number and trk expression in dorsal
root ganglia (DRG) of mouse embryos. a Number of neurons in
mouse L1 DRG from embryonic day 11.5 (E11.5) to birth (P0/1). Data
from Farinas et al. 1996 (white bars), and Coppola et al. 2001 (blue
bars). b Number of neurons (red), TUNEL-positive profiles (green)
and BrdU-incorporating profiles (blue) in mouse SCG; from ElShamy
and Ernfors 1996. c, d Number and percentage, respectively, of L1
DRG neurons positive for trkA (white bars), trkB (grey bars) and trkC
(black bars) at the embryonic stages indicated. Data from Farinas et
al. 1998
Species Method Percentage of positive cells Reference
P0–2 P7 P14/15 P21 Adult
Rat IHC 71 60 45 − − Bennett et al. 1996a
74 − − − 31 Guo et al. 2001
79 60 − 45 42 Benn et al. 2001
Mouse IHC ∼80 62 52 − 42 Molliver and Snider 1997
Table 3 Postnatal trkA expres-
sion in mammalian DRG (IHC
immunohistochemistry)
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trkB is expressed in a restricted population of DRG neurons
trkB-immunoreactive cells amount to 40% of thoraco-
lumbar DRG neurons in E11 mice and do not
incorporate BrdU (Farinas et al. 1998). At this stage,
neurons are observed to coexpress trkB and trkC in
addition to cells showing only trkB or trkC immunoreac-
tivity. The incidence of trkB/trkC double-positive neurons
in lumbar DRG is ~75% at E11.5, drops to ~40% at E12
and to ~10% at E12.5; by E14.5, no coexpression is
detected (Kramer et al. 2006). The proportion of thoraco-
lumbar DRG neurons in mice staining with trkB antibody
is reduced to ~8% at E13, the absolute number of trkB-
positive cells at E13 amounting to approximately 50% of
that at E11 (Farinas et al. 1998; Fig. 2).
trkB mRNA is detected by ISH in embryonic rats in a
subset of DRG cells at E13 (Ernfors et al. 1992; Mu et al.
1993). Reported percentages in thoracolumbar DRG at E15
in rat and neonatally in rat and mice are close to 10% (Mu
et al. 1993; Liebl et al. 1997, 2000).
In thoracic DRG of adult rats, 10% of the neurons
express trkB mRNA at high levels and an unquantified
subset of neurons at low levels as detected by ISH (Wright
and Snider 1995). In L4/5 DRG of adult rats, 26% of
neurons express trkB mRNA (Wetmore and Olson 1995).
Expression of the full-length tyrosine-kinase-containing
trkB isoform is confined to neurons in the lumbar DRG,
whereas truncated non-catalytic trkB isoforms are
expressed in non-neuronal cells (McMahon et al. 1994;
Wetmore and Olson 1995). Retrograde labelling from
various nerves (see below) in adult rat indicates that trkB
mRNA colocalizes with trkA in a subset of DRG neurons
projecting to visceral nerves and with trkC in some neurons
projecting to muscle (McMahon et al. 1994). Coexpression
might be restricted to neurons expressing low trkB mRNA
levels (for a discussion, see Snider and Silos-Santiago
1996).
trkC is expressed in almost all mouse DRG neurons
at E11.5 and prevalence drops to less than 10% at E13
trkC immunoreactivity is detected in a few neurons of
mouse thoracolumbar DRG at E10 and is widespread at
E11 with approximately 70% of positive neurons (Farinas
et al. 1998). In mouse cervical DRG, strong expression in
the majority of cells is observed at E10.5 (Phillips and
Armanini 1996). The onset of trkC expression in lumbar
DRG precedes that of trkB by about half a day (Kramer et
al. 2006). At E11.5, almost all cells in the lumbar DRG are
intensely positive for trkC mRNA, as shown by ISH (White
et al. 1996). Thereafter, mRNA expression is downregu-
lated in lumbar and cervical DRG (White et al. 1996;
Phillips and Armanini 1996). trkC-immunoreactive cells in
mouse thoracolumbar DRG at E13 amount to less than 10%
of the neuron population and the absolute number at this
stage is reduced by 50% or more compared with that at E11
(Farinas et al. 1998; Fig. 2). In neonatal mice, less than
30% of neurons in L4 DRG are trkC-positive as detected by
ISH (Liebl et al. 1997, 2000). The elevated postnatal values
may be attributable to a later phase of trkC expression
during the third embryonic week (Farinas et al. 1998).
In the lumbar DRG of adult rats, 21% of the neurons
express trkC mRNA (Wetmore and Olson 1995). Expres-
sion patterns for trkC isoforms with and without the kinase
domain are similar and restricted to neurons (McMahon et
al. 1994).
trkC is expressed in mitotically active cells of chick DRG
None of the trkC-immunoreactive cells in mouse thoraco-
lumbar DRG are reported to incorporate BrdU and cells
show neuronal bipolar morphology and neurofilament 150-
kDa immunoreactivity suggesting that trkC protein is
expressed in postmitotic neurons and not in mitotically
active precursors (Farinas et al. 1998). In chick embryo
DRG at brachial levels, however, trkC immunoreactivity is
coexpressed with markers of neuronal progenitors and
postmitotic neurons (Rifkin et al. 2000). Of the cells in
the interior region of DRG from E4 chick, judged to be
dividing by structural criteria, 20% are trkC-positive. This
has been confirmed by BrdU labelling and staining for
phosphorylated histone H3. The reason for the discrepancy
between mouse and chick is not clear. trkC mRNA as
detected by ISH is found in neural crest cells of both
species (Tessarollo et al. 1993; Kahane and Kalcheim 1994)
and NT3, the high-affinity ligand for trkC, is a mitogen for
cultured neural crest cells of quail (Kalcheim et al. 1992).
trkC is expressed early and coexpressed with trkA and trkB
at the onset of their expression in DRG of avian embryos
trkC mRNA is found in chick embryos by ISH even in
migrating neural crest (Kahane and Kalcheim 1994) and
immunoreactivity is clearly detectable in mitotically active
precursors (Rifkin et al. 2000). trkC mRNA has been
shown in avian DRG while the ganglia are in the process of
forming (Zhang et al. 1994; Rifkin et al. 2000). Strong and
uniform trkC expression throughout the DRG lasts until E6
when expression becomes heterogeneous (Zhang et al.
1994; Kahane and Kalcheim 1994; Rifkin et al. 2000). At
E3.5–E5, ~85% of the cells immunoreactive for the
neuronal marker Hu are trkC-positive in quail DRG (Zhang
et al. 1994) and 63% of all cells are reported to be trkC-
immunoreactive in chick DRG (Rifkin et al. 2000). At E6,
this value has dropped to 28% and increases again to 48%
at E15 in quail (Zhang et al. 1994).
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trkA-immunoreactive cells are detected only occasionally
in DRG of E3 chick (Rifkin et al. 2000). At E4.5, 23% of the
nascent DRG cells are trkA-positive. trkA mRNA expression
is detectable later by ISH in quail embryos and remains
consistently at 73% of Hu-positive cells from E6 to E15, the
last stage analysed in the study of Zhang et al. (1994).
trkB expression in chick DRG begins at E3; by E4.5,
47% of the nascent DRG cells are trkB-immunoreactive
(Rifkin et al. 2000). At early stages (E3.5), 100% of trkA-
and trkB-immunoreactive cells coexpress trkC. trk-positive
subpopulations only begin to segregate at E6.
In summary, both the chick and mouse data show that
trkC appears first, quickly followed by trkB, with trkA
being the last trk turned on.
trk expression in sensory neurons projecting to various
target organs
trk mRNA expression has also been studied in adult rat
DRG neurons projecting to various target tissues after
retrograde labelling by fluoro-gold applied to a varaiety of
nerves (McMahon et al. 1994). Application to the sciatic
nerve yields the same results as analysis of DRG neurons,
independent of their target projection: 44% trkA-positive,
27% trkB-positive and 17% trkC-positive cells. Application
to the cutaneous saphenous nerve gives similar results: 48%
trkA-expressing, 16% trkB-expressing and 10% trkC-
expressing cells. The picture is different for the lateral
gastrocnemius nerve supplying skeletal muscle: 20% trkA-
positive, 50% trkB-positive and 73% trkC-positive cells.
Again, the situation in the visceral pelvic nerve is different:
90% trkA-positive, 94% trkB-positive and 2% trkC-
positive cells. The data again support the concept of
specific trk receptor expression in the different sensory
neuron populations. In addition, they demonstrate that, in
muscle and visceral sensory neurons, different trks must be
coexpressed in adult rat.
trkA expression in innervating DRG neurons in the adult
rat has been analysed by IHC after retrograde labelling by
dye applied to two different target tissues, viz. skin and
bladder (Bennett et al. 1996b): 43% of cutaneous afferents
are trkA-immunoreactive and 51% express the peptide
CGRP. Of the visceral afferents, 75% are trkA-positive and
69% express CGRP.
Electrophysiological characterization shows that most,
but not all, trkA-positive cells have nociceptor properties
TrkA expression preferentially in nociceptive neurons was
confirmed by the analysis of electrophysiologically charac-
terized DRG neurons in rat (Fang et al. 2005). Intracellular
recordings were performed on L3-L6 DRG neurons from
young adult animals and sensory properties were deter-
mined by mechanical and thermal stimulation of hindlimb
and flank. Of neurons identified as nociceptors, 78% were
trkA-immunoreactive, 61% showing strong trkA signal and
the remainder being weakly positive. Strong trkA signal
was restricted to nociceptors. In the C fibre domain, 75% of
nociceptive units expressed trkA: five out of eight analysed
high-threshold mechanoreceptor (HTMR) units, two of two
mechanocold receptors and one of two polymodal noci-
ceptors are positive, whereas only one of three low-
threshold mechanoreceptors (LTMR), judged as
non-nociceptive, expresses trkA. In the Aδ fibre domain,
93% of nociceptive units are trkA-positive and three out of
five LTMR are positive. Of nociceptive units in the Aα/β
domain, 70% express trkA: all HTMR but no LTMR with
such conduction velocities are trkA-positive. In the same
study, trkA expression in DRG neurons of various soma
sizes has confirmed its preferential presence in small
neurons: 75% of small cells, 58% of intermediate and
43% of large cells are trkA-positive (Fang et al. 2005). In
this study, overall 70% of DRG neurons have been
classified as trkA-positive including 37% strongly positive
cells and 33% weakly positive cells.
Neuropeptide expression in DRG
Immunhistochemical detection of the neuropeptide, SP, in a
subset of DRG neurons (Hökfelt et al. 1975) marks the onset
of a neurochemically based classification of sensory neurons.
SP is expressed in 10%–40% of DRG neurons that are small
to medium in diameter (for a review, see Lawson 2002).
Upon electrophysiological characterization in the L6 and S1
DRG of guinea-pigs, all SP-immunoreactive neurons are
nociceptors but not all nociceptors are SP-positive (Lawson
et al. 1997; compare Leah et al. 1985). Of the cells in rat L4/
5 DRG that express preprotachykinin (PPT) mRNA coding
for SP, 78% are also positive for trkA, as shown by ISH,
whereas no overlap exists with trkB and trkC expression
(Kashiba et al. 1996). During development, no SP-
immunoreactive neurons are detected in rat DRG at E14.5,
few positive cells are found at E19.5 and adult numbers are
reached at birth (Hall et al. 1997; see also Marti et al. 1987).
Approximately 20%–50% of DRG neurons express the
neuropeptide CGRP and these cells belong to all size
classes (for a review, see Lawson 2002). Numbers vary
with target tissue (Kashiba et al. 1991; Bennett et al.
1996b), segmental level (Ohtori et al. 2003) and even
between different specimens within one species (Tonra and
Mendell 1998). Electrophysiological characterization in the
L6 and S1 DRG of guinea-pigs shows CGRP immunore-
activity in many but not all nociceptors (Lawson et al.
2002). In addition, some A fibre, but no C fibre,
mechanoreceptors with low threshold in the non-
nociceptive range are CGRP-positive. Of cells expressing
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CGRP mRNA, 84% are trkA-positive and 6% express trkC,
whereas no coexpression is observed with trkB (Kashiba et
al. 1996). The first appearance of CGRP-immunoreactive
neurons in rat DRG is observed at E16 (Marti et al. 1987)
and few neurons are CGRP-positive at E18.5 in rat (Hall et
al. 1997) and E15 in mouse (Molliver and Snider 1997).
Their proportion increases to approximately adult numbers
after birth.
Thus, CGRP is expressed in DRG neurons of all size
classes, whereas SP is restricted to small and medium-
sized neurons. This observation is also reflected in the
conduction velocity range of the respective neurons. As
analysed in L4 DRG, SP-positive neurons belong to the C
fibre and Aδ fibre classes, whereas CGRP-positive
neurons belong to the C fibre, Aδ fibre and Aα/β fibre
classes (McCarthy and Lawson 1989, 1990). Consequent-
ly, SP is coexpressed in only a subpopulation of CGRP-
positive neurons in cervical to lumbar DRG (Ju et al. 1987).
Approximately 80% of CGRP or SP-positive cells express
trkA. No coexpression is observed for SP and trkC,
whereas a small proportion of CGRP-positive cells coex-
presses trkC but not trkB.
Ion channel expression in DRG
Analysis of ion channel expression and its regulation by NTs
has been performed in some detail in DRG neurons. Of
particular interest are the transient receptor potential (TRP)
family of ion channels that are involved in the transduction of
sensory stimuli in DRG neurons. Their expression correlates
in part with trk receptors and is reviewed in Ernsberger (2008).
In addition, voltage-gated sodium channels are of interest
because of their differential expression in DRG neuron
subpopulations, their classification-relevant kinetic properties
and their regulation by NTs.
The tetrodotoxin-resistant (TTXR) sodium channel
Nav1.8/SNS/PN3 is expressed in 50% of C fibre and 10%
of A fibre DRG neurons in adult rat (Tate et al. 1998;
Amaya et al. 2000). It is essential for the perception of pain
at cold temperatures (Zimmermann et al. 2007), although
immunoreactivity is detected not only in nociceptors, but
also in LTMR as analysed by electrophysiology and IHC of
labelled L4–L6 neurons in rats (Djouhri et al. 2003). In A
fibre, but not C fibre, nociceptors in rat L3–6 DRG, the
intensities of immunoreactivity for Nav1.8 and trkA are
correlated (Fang et al. 2005). The TTXR sodium channel
Nav1.9/SNS2/NaN is selectively expressed in small DRG
neurons (Tate et al. 1998) and is detected in nociceptive A
and C fibre neurons as analysed by electrophysiology and
IHC of labelled lumbar neuron in rats (Fang et al. 2002). In
C fibre nociceptors of lumbar DRG, Nav1.9 immunoreac-
tivity is correlated with isolectin-B4 (IB4)-binding levels
(Fang et al. 2006).
Expression is detected in rat L4/5 DRG by IHC at E15
for Nav1.8 and not before E17 for Nav1.9 (Benn et al.
2001). At E17, Nav1.8 is detected in ~25% of DRG
neurons, mainly trkA-positive cells. Approximately 80% of
trkA-immunoreactive cells are Nav1.8-positive at this stage.
The proportion of trkA-positive cells that also expresses
Nav1.8 decreases to ~60% at P7 and to ~40% in adult
animals. A similar proportion binds IB4 in adult animals,
whereas only ~10% of IB4-binding neurons are Nav1.8-
positive at E17. Approximately 50% of total cell profiles
are Nav1.8-immunoreactive from P7 to adulthood. The
proportion of trkA-immunoreactive and IB4-binding neu-
rons positive for Nav1.9 ranges between 40%–50% and
60%–70%, respectively, in postnatal L4/5 DRG.
Generation of diverse expression profiles during
embryogenesis
Developmental regulation of gene expression during em-
bryogenesis occurs along fundamentally different pathways
(Ernsberger 2008). The initial widespread or ubiquitous
expression of trkC throughout the cell population in DRG
and sympathetic ganglia becomes restricted between E11
and E13 in mouse DRG and, after E13, in SCG to small
neuron subpopulations. In contrast, trkA expression, which
commences after trkC expression, increases progressively
during the second embryonic week in SCG and between
E10 and E13 in DRG, such that virtually all (SCG) or the
vast majority (DRG) of neurons are positive at birth.
A progressive increase in expression has also been
observed for SP and CGRP in mouse DRG after induction
during the third week of embryonic development. For SP,
the adult complement of rat DRG neurons expressing the
peptide appears present at birth, whereas for CGRP, the
number of positive neurons continues to increase postna-
tally. Postnatal regulation, albeit as a decrease in the
proportion of positive cells, is observed for trkA in DRG,
where the proportion of cells expressing the high-affinity
NGF receptor drops by ~50%. With regard to the voltage-
gated sodium channel Nav1.8, for which detailed counts are
available during rat development, the adult complement of
positive cells appears to be established at birth.
The available data show that induction of the expression
of genes coding for the various neuronal differentiation
markers occurs embryonically (Table 4, compare Table 2 in
Ernsberger 2008) and that population-specific expression
can be established during embryogenesis by a progressive
restriction from an initially widespread expression or by a
progressive increase in the number of positive cells. For
certain markers such as SP, Nav1.8 and trkB, the adult
complement of positive DRG neurons appears to be
established at birth. For others, the prominent regulation
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of the size of the positive cell population occurs postnatally.
The postnatal loss of trkA expression in a significant
number of DRG neurons depends on ret signalling (Luo et
al. 2007). In sympathetic neurons, the massive postnatal
increase in the proportion of cholinergic neurons depends
on gp130 signalling (Stanke et al. 2006). Both events are
transdifferentiation processes in existing cell populations,
independent of proliferation or cell death.
Comparison of expression patterns for NT receptors
and receptors for the glial-cell-line-derived neurotrophic
factor family of ligands
Both the receptors for NTs (this review) and for the
glial-cell-line-derived neurotrophic factor family of
ligands (GFL; for a review, see Ernsberger 2008) are
expressed in subpopulations of sympathetic and DRG
neurons. This raises the question as to whether receptor
expression delineates developmental stages and pathways
possibly conserved between sympathetic and DRG
neurons.
The developmental expression pattern of trkA and trkC
receptors in rodents shows remarkable similarities between
both neuron populations. In DRG and sympathetic ganglia,
an initially widespread trkC expression yields to expression
in small subpopulations at birth. With a delay, trkA
becomes expressed in an increasing proportion of neurons
in both classes of ganglia. Unlike adult sympathetic ganglia
in which all neurons appear trkA-positive, only 40% of
adult DRG neurons express trkA because of postnatal
downregulation from 80% of trkA-positive cells in new-
born animals. The situation is less clear for trkB for which
ISH and IHC data for sympathetic ganglia are not in
agreement.
ret, the signal transducing subunit of the GFL receptor
complex, is detectable in mouse DRG and sympathetic
ganglia at E11.5. Whereas expression occurs throughout the
sympathetic ganglia at this stage, expression in DRG is
initially limited to a few large neurons and appears in small
DRG neurons only at later stages. Thus, widespread ret
expression in mouse SCG appears to precede the trkA
expression that commences at E13.5, whereas in mouse
DRG, 80% of neurons are trkA-positive at E15 when only
10% of the neurons express ret. Therefore, ret expression
appears to precede trkA expression in the bulk of
sympathetic neurons, whereas the opposite holds true for
the majority of DRG neurons. Even though the analysis of
the developmental expression pattern of the receptor alpha
subunits, GFRalphas, is incomplete, the data strongly
suggest that the sequential appearance of NT and GFL
signalling does not define a developmental progression
conserved between sympathetic and DRG neurons.
Role of NTs and their high-affinity receptors in DRG
neuron development
The massive effect of mouse sarcoma-derived neurotrophic
activity, later characterized as NGF, on the peripheral
nervous system of chick embryos included an increase in
DRG cell numbers by 20%–50% (Levi-Montalcini and
Hamburger 1951). Transgenic overexpression of NGF in
the skin reproduced the dramatic effect of growth factor
supply on neurite outgrowth (Albers et al. 1994) and DRG
neuron counts (Mendelson et al. 1996). Experiments
increasing NGF levels are nicely complemented by deple-
tion studies with antibody injection or autoimmunization
(for reviews, see Johnson et al. 1986; Snider 1994). These
studies suggest a survival effect on nociceptive DRG
neurons, an effect that is prominent during embryogenesis
and lost rapidly after birth. Analysis of mice mutant for
NGF and its high-affinity receptor trkA has confirmed the
requirement of this signalling pathway for the survival of
small and intermediate DRG neurons, including peptidergic
and non-peptidergic nociceptors, but sparing large trkB-
and trkC-positive cells (for reviews, see Snider 1994;
Snider and Silos-Santiago 1996). In addition, mutant mice
have allowed the precise characterization of the timing of
the survival requirement for trkA signalling and, in
combination with mutation of the proapoptotic Bax gene,
the analysis of neurite outgrowth and differentiation effects.
Table 4 Onset of expression of receptors and function-specific
markers (>< onset of expression between the indicated time points,
< onset not precisely shown but positive cells found at the time
indicated). Expression analysed by in situ hybridization (ISH) or
immunohistochemistry (IHC)
Marker Rat (method) Mouse (method)
Dorsal root ganglia
trkA − E10.5 (ISH/IHC)a
trkB − <E11 (IHC)b
trkC − <E10 (IHC)b
SP E14.5><19.5 (IHC)c −
CGRP E16 (IHC)c <E15 (IHC)
Nav1.8 <E15 (IHC) −
Nav1.9 Not before E17 (IHC) −
Sympathetic ganglia
trkA E14.5><E16 (ISH) E13.5 (ISH)
trkC <E13 (ISH)b <E11.5 (ISH)b
a Partial postnatal downregulation
b Initially widely expressed, embryonic downregulation to neuronal
subpopulation
c Adult numbers reached at birth
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Mutational inactivation of NGF and trkA genes shows
their role in survival and neurite outgrowth during
embryogenesis
In homozygous NGF and trkA mutant mice analysed
during the first two postnatal weeks, DRG neuron number
is reduced by 70%–90%, with small neurons being
preferentially affected (Crowley et al. 1994; Smeyne et al.
1994; Patel et al. 2000). Nociception is compromised in
these animals. Whereas trkA-positive cells are lacking in
NGF mutants, these animals show no apparent effect on the
trkB- and trkC-positive neuron population (Crowley et al.
1994).
In both NGF and trkA mutant mice, increased apoptosis
can be observed at E13.5 (White et al. 1996). No obvious
difference from the wildtype is found at E11.5 and the
apoptosis level at E15.5 is even lower in trkA mutants than
in wildtype animals. With increased apoptosis, ganglion
areas become dramatically reduced and neuron counts
performed at E17.5 show a 79% loss in cell numbers in
L4/L5 DRG. This deficit in cell number is maintained and
shows that NGF plays a crucial role for survival between
E11.5 and E15.5. In mice in which both trkA and Bax have
been mutated, cell loss is eliminated (Patel et al. 2000) and
cell numbers in the L4 DRG of newborn mice are 160%
that of the wildtype in contrast to the 90% loss in trkA
mutants. Moreover, in NGF/Bax double-mutants, cell loss
is also eliminated and ganglion size is comparable with that
of the wildtype.
Cell loss affects preferentially small neurons in NGF
(Crowley et al. 1994) and trkA (Smeyne et al. 1994;
Silos-Santiago et al. 1995) mutant mice. In the dorsal root,
more than 95% of unmyelinated axons are lost and the
number of myelinated axons is reduced by 50% in trkA
mutants , including the majori ty of Aδ axons
(Silos-Santiago et al. 1995). As shown by DiI labelling,
the vast majority of the dorsal root projection to laminae I
and II in the dorsal horn of the spinal cord is eliminated in
trkA mutant mice. In contrast, Ia afferent fibres projecting
to the ventral horn of the spinal cord are not affected by
trkA mutation (Liebl et al. 1997). The data demonstrate that
NGF signalling is crucial for nociceptor but not proprio-
ceptor development. Since projection is rescued in Bax
mutants and as trkA-immunoreactive fibres are found in the
superficial dorsal horn of NGF/Bax double-mutants similar
to wildtype (Patel et al. 2000), the disrupted nociceptor
projection to spinal cord target areas in NGF and trkA
mutant mice appears secondary to cell death. As synapse
formation has not been analysed, however, it remains
unclear whether normal synaptic connectivity is rescued in
the double-mutant animals. In the periphery, loss of fibres
in trkA mutants has been shown in the cutaneous
saphenous nerve and hindlimb skin by staining for
PGP9.5 (Patel et al. 2000). Importantly, this loss is not
reversed in NGF/Bax double-mutants, demonstrating that
NGF signalling is required for peripheral target innervation,
independently of cell survival. Correspondingly, no trkA-
positive axons can be found in the distal hindlimb of NGF/
Bax double-mutants.
The data show an increased loss of neurons in the
absence of NGF and trkA signalling at the end of the
second embryonic week in mutant mice; this can be rescued
by mutation of the Bax gene. Whereas the defects in the
central projection of sensory neurons in mutant mice are
compensated by rescue from cell death, the NGF require-
ment for neurite outgrowth to peripheral targets is indepen-
dent of the survival effect and cannot be rescued by the Bax
mutation.
trkA/Bax double-mutant mice show embryonic NGF
requirement for neuropeptide induction
A specific requirement for NGF during the embryonic
development of the SP-positive population of DRG neurons
is apparent from NGF depletion studies. Anti-NGF antibody
injection at E16.5 into rats results in a 86% decrease in SP-like
immunoreactivity in DRG as analysed by radioimmunoassay
at 4 months of age and depletion of SP as shown by IHC in
lamina I and II of the spinal cord (Goedert et al. 1984; Ruit et
al. 1992). Moreover, in adult animals, anti-NGF antibody
injection leads to decreased SP protein (Shadiack et al.
2001). In addition, CGRP protein is decreased, whereas
peptide and RNA for galanin and vasoactive intestinal
peptide (VIP) are increased. This resembles the changes that
are observed after the axotomy of sensory neurons (Verge et
al. 1995; Shadiack et al. 2001) and that can be reduced by
NGF infusion (Verge et al. 1995).
Expression of SP and CGRP is likewise compromised
in DRG of NGF or trkA mutants. In NGF mutant mice,
the immunoreactivity for both peptides is reduced in
DRG (Crowley et al. 1994). Only a few cells weakly
stained for CGRP can be detected in ganglia of 3-day-old
mutant animals and immunoreactive axonal processes are
completely absent in both the dorsal horn of the spinal
cord and the hairy skin. Similarly, in trkA mutant animals,
CGRP immunoreactivity in the dorsal horn is virtually
eliminated and few if any positive DRG neurons are
observed at P15 (Silos-Santiago et al. 1995). In DRG of
newborn trkA mutant animals, CGRP is not detected by
IHC (Patel et al. 2000; Moqrich et al. 2004) or ISH
(Minichiello et al. 1995).
SP immunoreactivity is also eliminated at both stages
(Silos-Santiago et al. 1995; Patel et al. 2000). ISH in
neonatal animals has shown that SP mRNA expression is
reduced in trkA mutant animals, although Minichiello et al.
(1995) report 16% of positive cells remaining from 39% in
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wildtype animals, in contrast to Patel et al. 2000 who have
reported the absence of SP mRNA.
The data show that NGF affects neuropeptide contents in
embryonic DRG but they leave open whether this is simply
attributable to its survival effect. In trkA/Bax double-
mutants, peptide expression is not restored (Patel et al.
2000) indicating that NGF is required not only for survival,
but also for differentiation. Since the Bax mutation does not
rescue the peripheral innervation deficits, the NGF effects
may be either direct or indirect via access to other target-
derived signals.
Cell culture studies indicate that NGF directly affects
neuropeptide expression. In DRG explant cultures from
E13.5 Bax mutant mice in which DRG neurons do not
require NGF for survival, NGF supplementation boosts the
proportion of CGRP-immunoreactive cells after 3.5 days to
41% as compared with a few cells in untreated cultures
(Patel et al. 2000). This establishes the ability of NGF to
induce neuropeptide expression in the ganglion cell
population independently of target access. As 80% of
mouse DRG neurons express trkA even at E13, the
question remains as to whether all trkA-positive cells can
be induced to express CGRP after NGF treatment. In
dissociated cultures from the DRG of E14.5 rat, prepared
before CGRP immunoreactivity is detectable in vivo,
supplementation with NGF, which is required for survival,
does not result in the widespread expression of CGRP
immunoreactivity (Ai et al. 1999). Only 14% of neurons are
CGRP-immunoreactive after 8 days in NGF-treated
cultures.
In a study of neurons differentiating from precursor cells
of embryonic chick DRG, the percentage of SP-
immunoreactive cells, surprisingly, does not differ in
cultures treated with NGF or BDNF (Ernsberger and
Rohrer 1988). This may reflect a peculiarity of avian
DRG neurogenesis, since the vast majority of chick DRG
neurons are SP-immunoreactive early during embryogene-
sis (Duc et al. 1991).
Taken together, the studies show that NGF is required
for the development of the normal complement of SP- and
CGRP-positive DRG neurons. In vitro, NGF can directly
induce neuropeptide expression in mouse DRG neurons at
embryonic stages.
NGF/Bax double-mutant mice show NGF requirement for
development of small-diameter ret-positive DRG neurons
In addition to peptidergic nociceptors, DRG contain a
population of small-diameter nociceptors that do not
express the neuropeptides SP and CGRP. Instead, these
neurons express the receptor tyrosine kinase ret (for a
review, see Ernsberger 2008). Small-diameter DRG neurons
expressing ret are generated from trkA-positive cells during
the third week of mouse embryogenesis and, to a large
extent, lose trkA expression postnatally. Analysis in NGF/
Bax double-mutant mice demonstrates that these cells
require NGF not only for survival, but also for ret
expression (Luo et al. 2007). In newborn animals, ret
mRNA levels in small DRG neurons as detected by ISH are
greatly reduced and the proportion of positive cells is
decreased from 62% to 31%. In addition, mRNA for the
receptor alpha subunit GFRalpha1 is completely absent
from mutant DRG and the proportion of GFRalpha2-
positive cells is decreased from 18% to 9%. The percentage
of GFRalpha3-positive cells is unaltered (35%). In cultures
from DRG neurons, NGF increases the expression of
mRNAs for ret, GFRalpha1 and GFRalpha2, but not for
GFRalpha3, as analysed by RT-PCR (Luo et al. 2007).
The data show that NGF signalling is not only required
for the differentiation of peptidergic nociceptors, but is also
necessary for the normal expression of ret, the marker and
signalling component of nonpeptidergic nociceptors. The
culture experiments indicate that NGF acts directly rather
than by promoting neurite outgrowth and access to other
growth factors.
NGF is involved in embryonic regulation of TRP channel
expression
The TRP channel family contains thermosensitive and
chemosensitive ion channels involved in the transduction
of the respective stimuli in sensory neurons (for reviews,
see Jordt et al. 2003; Dhaka et al. 2006). In DRG, they are
expressed in subpopulations and overlap with trkA expres-
sion (for a review, see Ernsberger 2008). The heat- and
capsaicin-sensitive TRPV1 channel is expressed in ~50% of
trkA-positive cells in adult rat DRG and ~50% of TRPV1-
positive cells express trkA. The cold- and menthol-sensitive
TRPM8 channel is expressed in ~40% of trkA-positive
cells and virtually all TRPM8-positive cells express trkA
(Kobayashi et al. 2005).
Expression of both channels in DRG neurons is
compromised by the lack of NGF signalling. ISH on
DRG from newborn NGF/Bax double-mutant mice reveals
a reduction in the number of TRPV1-mRNA-expressing
cells by ~30% and of TRPM8-mRNA-expressing cells by
more than 80% (Luo et al. 2007). The data show that NGF
signalling is required for the embryonic development of the
normal complement of TRPV1- and TRPM8-expressing
cells.
NGF affects Aδ and C fibre sensitivities postnatally
NGF administration and depletion in vivo affects the
receptive properties of C fibre and Aδ fibre DRG neurons
and demonstrates an important role of NGF for postnatal
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development of nociceptive afferents (for a review, see
Lewin and Mendell 1993). In rats that received NGF
injections for the first two postnatal weeks, mechanical
thresholds of Aδ HTMR recorded from L5 dorsal roots are
reduced compared with controls when recorded between 5
and 7 weeks of age (Lewin et al. 1992, 1993). At 10–
13 weeks, the effect has disappeared indicating that NGF
injection in newborn rats leads to a lasting, but not
permanent, alteration in Aδ nociceptors. C fibre nociceptors
from animals injected with NGF on P2–P14 and analysed at
the adult stage show increased heat sensitivity such that
60% can be classified as mechanosensitive and heat-
sensitive units (C-MH) in contrast to 30% in control
animals in which the majority of units is only mechano-
sensitive (C-M; Lewin and Mendell 1994). This change is
still observed in 4-month-old animals.
After the injection of anti-NGF antibodies into rats
from P2 to P14, DRG cell counts do not differ
significantly from control indicating that requirement
for NGF for survival is lost rapidly postnatally (Lewin
et al. 1992). However, abundance of Aδ HTMR recorded
from L5 dorsal root and driven by sural nerve stimulation
decreases to 16% as compared to control 41–49% (Lewin
et al. 1992; Lewin and Mendell 1994). In addition, the
mechanical thresholds of Aδ HTMR increase. In parallel
to the loss of Aδ HTMR, abundance of D hair afferents
increases from 29% to 51% (Lewin et al. 1992). The
significance of the observation that D hairs might replace
HTMR is still unclear and the authors suggest this to be
attributable to a redirection of fibres to the dermis and
signals therein in experimental animals.
The data show that mechanical sensitivity in Aδ HTMR
and heat sensitivity in C fibre nociceptors can be increased
by NGF administration in postnatal animals. Experiments
involving the injection of anti-NGF antibodies do not yet
provide an answer to the question as to whether an NGF
supply is required for the development of normal mechan-
ical and heat sensitivity. Instead, they show an increase in
abundance of D hair afferents at the expense of Aδ HTMR.
A molecular analysis of this effect might shed light on the
lineage relationship between HTMR and LTMR.
NGF affects temperature but not mechanical sensitivity
of Aδ and C fibre units in adult rats
NGF injection in juvenile (2–5 weeks old) or adult rats does
not result in alterations of adaptation properties or mechan-
ical thresholds of Aδ HTMR, indicating that this pheno-
typic plasticity is restricted during development (Lewin et
al. 1993). Heat sensitivity of Aδ and C fibre units, however,
remains subject to regulation by NGF, even in adult
animals. In a saphenous nerve/skin preparation from adult
rats, perfusion of receptive fields from Aδ and C fibre units
with NGF induces a significant increase in heat sensitvity
without changing cold or mechanical sensitivity (Rueff and
Mendell 1996). Upon NGF depletion by injection of trkA-
IgG into skin of adult rats, the proportion of nociceptors
responding to heat in a sural nerve/skin preparation drops
from 57% to 32% (Bennett et al. 1998). The percentage of
nociceptors responding to noxious cold is unaltered,
however. Thus, heat sensitivity in slowly conducting DRG
afferents, unlike mechanical and cold sensitivity, appears to
be NGF-sensitive throughout life in rats.
In vitro, NGF enhances the heat response of TRPV1-
positive small-diameter neurons from adult lumbar DRG
within minutes of application (Galoyan et al. 2003).
Because of the rapid onset of heat sensitization, the process
must occur posttranslationally and several signalling path-
ways affecting TRPV1 activity have been characterized
leading to TRPV1 phosphorylation and its insertion into the
plasmamembrane (Zhang et al. 2005; Huang et al. 2006).
Rapid sensitization is not observed in trkA-positive neurons
from early postnatal animals (Zhu et al. 2004) indicating a
developmental alteration in the regulation of heat sensitivity
by NGF. In addition to posttranslational regulation, NGF
might regulate TRPV1 mRNA levels. Over extended
culture periods (3–10 days) of DRG neurons from adult
rats, NGF can maintain higher numbers of TRPV1-mRNA-
positive and TRPV1-immunoreactive cells (Ogun-Muyiwa
et al. 1999; Bron et al. 2003) and increase TRPV1 mRNA
levels in comparison with controls as found by Northern
Blot (Winston et al. 2001). NGF also prevents the decline
in the number of cold-sensitive DRG neurons with time in
culture as analysed via the cold-induced elevation of
intracellular calcium concentration (Babes et al. 2004).
NGF increases the proportion of menthol-sensitive cold-
responsive neurons suggesting a regulation of TRPM8, the
menthol-sensitive cold receptor.
These culture studies show that heat-sensitive TRP
channels in adult DRG neurons can be regulated by NGF
at the mRNA level and posttranslationally. They also
suggest that cold-sensitive channels may, under certain
conditions, be the target of NGF regulation.
NGF is involved in inflammation-induced plasticity
of DRG neuron properties
NGF levels are increased in inflamed tissue and contribute
to alterations in sensory neurons that convert exclusively
noxious stimulus detectors to sensors for innocuous inputs
(for reviews, see Lewin and Mendell 1993; Woolf 1996;
Pezet and McMahon 2006; Woolf and Ma 2007). The
alterations are attributable to early posttranslational changes
and later transcription-dependent modulation of neuronal
properties (for reviews, see Woolf and Costigan 1999;
Woolf and Ma 2007), both of which change the basal
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sensitivity of nociceptors and elicit stimulus-evoked
hypersensitivity.
Following inflammation induced by complete Freud’s
adjuvant (CFA) in the hindpaw of an adult rat, the number
of PPT-mRNA-expressing neurons in L3/4 DRG triples
within 48 h (Leslie et al. 1995). Anti-NGF antibody injection
prevents the induction of PPT expression. In addition, CFA-
induced inflammation induces the expression of the heat
receptor TRPV1 within 1 day after application. Protein levels
are increased as shown by Western blot and IHC (Ji et al.
2002; Amaya et al. 2004), whereas mRNA levels appear
unaltered as shown by RNase protection (Ji et al. 2002). The
increase in TRPV1 immunoreactivity is prevented by
neutralizing NGF with anti-NGF antisera. Carrageenan-
induced inflammation sensitizes nociceptors to heat, an
effect blocked by NGF-neutralizing trkA-IgG (Koltzenburg
et al. 1999). Expression of the cold receptor TRPA1, but not
TRPM8, is increased after CFA-induced inflammation within
1 day as observed by RT-PCR and ISH for mRNA detection
(Obata et al. 2005). Intrathecal administration of anti-NGF
antiserum decreases this induction.
The above studies thus show that NGF as a mediator of
inflammatory processes might alter gene expression pat-
terns in adult DRG thereby modulating sensory neuron
properties. Various mechanisms appear to be involved as
protein levels can be increased independently of or in
correlation with the induction of mRNA. In the case of the
peptidergic nociceptors, this may lead to a massive yet
transient alteration in apparent population size.
NGF affects expression of TTXR sodium conductances
in DRG neurons
In addition to TRP ion channels, the expression of voltage-
gated sodium channels is affected by NGF. ISH and RT-
PCR analysis of adult rat DRG shows the differential
expression of several sodium channel α subunit mRNAs
suggesting a molecular basis for the biophysical heteroge-
neity of sodium currents in these cells (Black et al. 1996).
In vitro evidence has demonstrated that NGF influences
sodium current expression and diversity in cultured adult
rat DRG neurons (Omri and Meiri 1990). In particular, the
percentage of cells with TTXR sodium conductances is
increased by NGF (Aguayo and White 1992). NGF
depletion in vivo by immunization decreases TTXR current
density as analysed by whole-cell patch clamping in freshly
dissociated IB4-negative neurons, which represent the
subpopulation of trkA-positive nociceptors in adult rat
(Fjell et al. 1999a). The changes are accompanied by
decreases in the mRNA hybridization signal for the
voltage-dependent sodium channel Nav1.8/SNS showing
reduced expression in SNS-positive cells and a smaller
proportion of positive cells.
NGF overexpression in mice from the K14 keratin
promoter results in elevated Nav1.8/SNS mRNA expres-
sion levels and also affects other voltage-gated sodium
channels (Fjell et al. 1999b). This study has not clarified
whether the percentage of positive cells changes. In
dissociated cultures of adult rat DRG neurons, Nav1.8/
SNS mRNA decreases with time and this decrease is
attenuated by NGF (Black et al. 1997). A correlation
between mRNA levels and the amplitude of TTXR peak
currents has been found in some, but not all, studies (Fjell
et al. 1999a; Dib-Hajj et al. 1998; but see Fjell et al. 1999b,
1999c).
These studies show that NGF regulates sodium channel
mRNA levels and TTXR current density in adult neurons
both in vivo and in vitro. Regulation during embryonic
development and for other sodium channel subunits
remains to be analysed.
Mutational inactivation of BDNF and trkB genes reveals
their role in specification of slowly adapting
mechanoreceptors
In BDNF mutant mice, 27%–36% of neuron loss has
been reported in DRG of animals analysed between P0
and P16 (Ernfors et al. 1994a; Jones et al. 1994; Liebl et
al. 2000; Agerman et al. 2003). During embryonic
development, the cell loss becomes apparent at E12.5,
when DRG cell number is reduced by 11% compared with
that in the wildtype (Liebl et al. 2000). By E13.5, cell loss
reaches 31%, close to the 36% reported for newborn
mutants in this study. Following mutation of the catalytic
domain of trkB, similar cell losses have initially been
reported in newborn animals (Klein et al. 1993;
Minichiello et al. 1995). The variability between DRG at
different axial levels is obvious, with a loss of neurons
ranging from approximately 20% to 50% at L1–L4. A
more recent study of trkB mutant mice from the same
source has found no difference in neuron number between
newborn mutant and wildtype animals; approximately
30% neuronal cell loss occurs in lumbar DRG only by
the second postnatal week (Silos-Santiago et al. 1997).
The reason for this discrepancy is not known.
The number and percentage of trkB-positive neurons is
reduced in newborn BDNF mutant mice, albeit the cells
have not disappeared completely (Liebl et al. 1997).
Moreover, the number of trkC-positive cells is reduced,
but not their proportion. In addition, 20%–30% of trkA-
positive cells are lost in newborn BDNF mutants, although
their proportion is unaltered as compared with that of the
wildtype (Liebl et al. 1997). No reduction in the number of
SP- and CGRP-positive DRG neurons is detectable in
neonatal animals mutant for BDNF (Liebl et al. 2000) or
trkB (Minichiello et al. 1995). The data show that the trkA-
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positive neurons lost in BDNF mutant mice are not
peptidergic nociceptors. Furthermore, proprioceptors appear
to be unaffected, since the number of cells immunoreactive
for parvalbumin, a marker for proprioceptive neurons, is
not significantly decreased in newborn BDNF mutant
animals (Liebl et al. 2000).
BDNF mutant animals show defects in movement
coordination and balance (Ernfors et al. 1994a; Jones et
al. 1994). Similarly, trkB mutant animals display orienta-
tion deficits in addition to disturbed feeding behaviour
(Klein et al. 1993). The movement disturbances may be
explained by massive cell loss in vestibular ganglia as
reported in BDNF mutant mice (Jones et al 1994; Ernfors et
al. 1994a).
In addition to the survival effects on sensory neurons,
the analysis of mutants has provided evidence for the role
of BDNF in the specification of slowly adapting mecha-
noreceptors (SAM), viz. DRG neurons that innervate
Merkel cells in touch dome complexes. In an in vitro
saphenous nerve/skin preparation, an increase in SAM
mechanical threshold has been found in homozygous
juvenile and heterozygous adult BDNF mutant animals
(Carroll et al. 1998). Other afferents (rapidly adapting, D
hair, AM) show normal properties and receptor prevalence
is not altered. Since Merkel cell number and morphology
are normal in touch domes of back skin and other receptor
types also appear unaltered, a specific effect of BDNF on
SAM properties must be assumed, rather than a general
alteration in the mechanical properties of the surrounding
tissue.
Acid-sensitive ion channel ASIC2/BNC1, a member
of the Deg/ENaC superfamily of ion channels, is
required for touch sensation in mice (Price et al.
2000). Its mutation leads to reduced mechanosensitivity
of rapidly adapting mechanoreceptor and SAM units but
not of D hair and AM receptors or C fibres. In DRG from
adult heterozygous BDNF mutant mice, the amount of
mRNA for ASIC2 is reduced by 20%–30% as compared
with the wildtype (McIlwrath et al. 2005). Primary
cultures from heterozygous animals exhibit reduced
ASIC2 expression, as detected by IHC. The percentage
of positive large and medium-sized neurons and the signal
intensity in large neurons are significantly reduced in
heterozygous BDNF mutants as compared with wildtype
animals. The addition of BDNF to these cultures increases
ASIC2 immunofluorescence in a transcription-dependent
manner.
Even though the DRG neuron populations that are lost in
BDNF mutant mice are not well defined, the importance of
BDNF signalling for slowly adapting mechanoreceptive
properties can be characterized in some detail. The control
of DEG/ENaC ion channel expression appears to play a
role in this process.
NT4 mutation results in altered prevalence of trkB-
and trkC-expressing neurons and loss of D hair afferents
NT4, the last member of the NT family identified, can
signal through trkB receptors but differs in its binding
requirements to the receptor (Minichiello et al. 1998).
Unlike BDNF mutation, mutational inactivation of NT4
does not lead to significant changes in DRG neuron counts
at E13 (96% of wildtype) and only to a small but significant
increase (113% of wildtype) in L4 ganglia of newborn mice
(Liebl et al. 2000). At 2 months of age, counts drop (to 86%
of wildtype), although no statistical significance is reported
(Liu et al. 1995). Correspondingly, the lack of an increase
in TUNEL staining provides no evidence for enhanced
apoptosis at E11–E13 (Liebl et al. 2000), whereas in 8-
week-old animals, a small number of TUNEL-positive
neurons is found in NT4 mutant animals but not in wildtype
mice (Stucky et al. 2002a).
In the saphenous nerve of adult NT4 mutant mice, the
number of myelinated axons is reduced by 16%–29%,
affecting particularly small myelinated fibres in the Aδ
range (Stucky et al. 1998; Liebl et al. 2000). In contrast,
myelinated axon number in tibial and peroneal nerve is
increased by 19% and 18%, respectively, suggesting an
increase in proprioceptive units (Liebl et al. 2000). In
parallel, the prevalence of trkB- and trkC-expressing
neurons changes in adult DRG. The number of trkB-
positive cells is reduced by 78% compared with that of the
wildtype, a change reported to occur between 5 weeks of
age and adulthood in one study (Stucky et al. 2002a). In
another study, even in newborn mice, their proportion is
reduced from 11% in wildtype to 1% in homozygous
mutants, whereas the percentage of trkC-positive cells
increases from 8% to 17% (Liebl et al. 2000). At the same
time, an increase occurs in the number of parvalbumin-
immunoreactive cells, but no reduction in CGRP- and SP-
positive cells (Liebl et al. 2000), indicating an effect on
proprioceptor but not nociceptor numbers.
An in vitro saphenous nerve/skin preparation shows an
almost complete loss of D hair receptors in adult NT4
mutant mice (Stucky et al. 1998). Their proportion among
Aδ fibres decreases from 35% in the wildtype to 4% in
homozygous mutants and the remaining units show atypical
electrical and mechanical properties. In skin, the number of
hair follicles encircled by myelinated fibres is reduced by
40%. AM fibres in the Aδ range show normal thresholds,
slowly adapting fibres in the Aβ range display normal
mechanical response and prevalence. C fibre mechanical
and heat sensitivity is unaltered. The effect of the NT4
mutation on D hair receptors becomes apparent around the
7th postnatal week (Stucky et al. 2002a). Whereas
myelinated axons are reduced as early as 5 weeks after
birth, D hair receptor number appears unchanged at this
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time point, as shown by electrophysiological investigation.
Other myelinated mechanoreceptors appear in normal
numbers.
These studies demonstrate that NT4 acts as survival
factor for a population of adult DRG neurons. In addition,
they show an alteration in the prevalence of trkB- and trkC-
positive neurons in newborn and adult mice. In parallel, the
number of neurons expressing the proprioceptor marker
parvalbumin is increased at birth.
NT3 mutation affects cell survival and the size of various
afferent neuron populations early in DRG development
Mutational inactivation of NT3 leads to a massive neuronal
deficit in DRG; a 60%–80% loss of cells is reported for
newborn animals (Farinas et al. 1994; Tessarollo et al.
1997; Liebl et al. 1997, 2000; Coppola et al. 2001) and a
55% loss for animals at P12–P16 (Ernfors et al. 1994b).
The reduction in neuron numbers in newborn trkC mutant
mice is distinctly smaller; a 17%–19% loss has been
reported for animals with a mutation in the trkC tyrosine
kinase domain (Klein et al. 1994; Minichiello et al. 1995;
Silos-Santiago et al. 1997) and a 27%–34% loss for animals
devoid of all trkC isoforms (Tessarollo et al. 1997; Coppola
et al. 2001).
Cell loss in mutant DRG becomes apparent early during
development. As early as E11.5 in NT3 mutant mice,
significant loss of total cells as analysed by Nissl staining
and loss of neurons as detected by IHC for neurofilament
have been reported (Farinas et al. 1996). The reduction in
cell number varies according to axial level and mouse line
(Farinas et al. 1996; ElShamy and Ernfors 1996; Liebl et al.
1997, 2000). Neuron loss increases with ongoing develop-
ment to reach ~70% at P0. This is in stark contrast to trkC
mutant animals in which neuron losses amount to ~30% at
P0, a value reached as early as E13.5–E14.5 (Liebl et al.
1997; Coppola et al. 2001). Whereas cell losses in NT3 and
trkC mutant animals have been shown to have a similar
time course until E13.5 in one study (Liebl et al. 1997),
neuron losses in NT3 mutants in another study exceed those
in trkC mutants even by E12.5 (Coppola et al. 2001).
Increased numbers of apoptotic cells have been observed
in DRG of both NT3 and trkC mutant mice as early as
E11.5 (White et al. 1996). At E13.5, their number in NT3
mutants exceeds that of trkC mutants. Quantification in
NT3 mutant animals shows a four-fold to six-fold increase
in TUNEL-positive cells and pyknotic profiles at E11 as
compared with wildtype animals (ElShamy and Ernfors
1996; Farinas et al. 1996; ElShamy et al. 1998). At E12 and
E14, numbers are still elevated, but only to 120%–150% of
the wildtype value. BrdU labelling has demonstrated a
deficit of proliferating cells in NT3 mutant cells even in
E11 DRG, but no change in their proportion (ElShamy and
Ernfors 1996; Farinas et al. 1996). Analysis of the
colocalization of TUNEL labelling with the differentiation
markers neurofilament and peripherin as compared with the
proliferation marker BrdU led to conflicting results. The
detection of TUNEL labelling in the majority of BrdU-
positive cells, the colocalization of the TUNEL label and
cell-cycle S-phase proteins and the occurrence of TUNEL
labelling in only a few peripherin-immunoreactive cells
have led to the conclusion that NT3 inflicts constraints on
the number of proliferating cells (ElShamy and Ernfors
1996; ElShamy et al. 1998). The absence of TUNEL and
BrdU colocalization together with TUNEL and neurofila-
ment colabelling in another study suggests that neuronal
apoptosis is important (Farinas et al. 1996).
In NT3 mutant animals, trkC-positive neurons are
partially depleted at E11.5 and have disappeared entirely
at E12.5/E13.5 (Tessarollo et al. 1994; Farinas et al. 1998;
Coppola et al. 2001). At those times when trkC immuno-
reactivity can be observed, it is mostly associated with
pyknotic profiles; TUNEL-positive cells are often, but not
always, stained with trkC antibodies (Farinas et al. 1998).
At E15.5, the reappearance of trkC staining in NT3 mutants
has been observed in a subset of DRG neurons (Farinas et
al. 1998) and, in newborn mutant animals, a small subset of
trkC-positive cells can be detected (Liebl et al. 1997).
Apoptosis is also seen in trkB-positive neurons of NT3
mutant mice (Farinas et al. 1998). In contrast to trkC-
expressing cells, however, numerous trkB-positive neurons
appear morphologically normal. At E11, trkB-positive cells
are reduced by 35%–40% in NT3 mutants. In newborn
animals, the loss of trkB-positive cells is even larger, i.e.
close to the reduction in total neuron counts of this study
(79%), and so the proportion of trkB-positive cells among
total neurons barely changes (Liebl et al. 1997). trkA-
expressing cells appear normal in NT3 mutant mice at E11
(Farinas et al. 1998). trkA immunoreactivity is not
associated with pyknotic profiles and the number of trkA-
positive neurons is not reduced in E11 animals (Farinas et
al. 1998). In newborn animals, however, the number but not
proportion of trkA-positive cells is reduced (Liebl et al.
1997). Again, the neuron loss closely parallels the reduction
in total neuron counts of this study (79%) and so the
proportion of trkA-positive cells among total neurons is
unaltered (Liebl et al. 1997).
Whereas the number of SP- and CGRP-immunoreactive
cells is not reduced in trkC mutant DRG (Minichiello et al.
1995), a 60%–65% loss of neurons immunoreactive for
these peptides is observed in DRG from E18.5 NT3 mutant
mice (Airaksinen and Meyer 1996). This loss is similar to
the loss in total neuron number and suggests the lack of a
specific effect on peptidergic nociceptors, but the presence
of an effect on the transition of precursors to differentiating
neurons.
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The large discrepancy between cell losses in NT3 and trkC
mutant mice points to an action of NT3 via other trk receptors;
this is supported by the survival effect of NT3 in cultures of
trkC mutant neurons (Davies et al. 1995). Both trkA and trkB
signalling might mediate non-trkC NT3 action (Davies et al.
1995; Farinas et al. 1998; Coppola et al. 2001).
NT3 is required for establishment of proprioceptor axon
projections
NT3 and trkC mutant mice show severe movement
disorders (Ernfors et al. 1994b; Tessarollo et al. 1994;
Farinas et al. 1994; Klein et al. 1994; Tojo et al. 1995). The
lack of muscle spindles and Golgi tendon organs has been
described for NT3 mutant mice (Ernfors et al. 1994b;
Farinas et al. 1994) and an absence of afferent contacts to
muscle has been observed from the first stage (E15.5)
onwards when they begin to develop in wildtype mice
(Kucera et al. 1995). The specific requirement of NT3 for
muscle proprioceptor development has also been demon-
strated by the lack of parvalbumin immunoreactivity, a
marker for proprioceptive neurons, in DRG, as analysed in
postnatal mutants (Ernfors et al. 1994b; Airaksinen and
Meyer 1996). Retrograde labelling of afferent projections to
the spinal cord by DiI application has demonstrated the loss
of group Ia afferents in postnatal mutant animals for NT3
(Ernfors et al. 1994b; Liebl et al. 1997) and trkC (Klein et
al. 1994; Liebl et al. 1997). In NT3 mutant mice,
developmental analysis has shown that projections from
the axial and thigh muscle to ventral layers of the spinal
cord are lacking as early as E13.5–E15.5 (Tessarollo et al.
1994, 1997; Kucera et al. 1995). In trkC mutant animals,
group II afferents are also missing (Klein et al. 1994),
whereas dorsal horn innervation appears grossly normal. In
contrast to the disturbed proprioceptor projections, DiI
application to dorsal roots shows a grossly normal central
projection of cutaneous afferents in NT3 mutant mice
(Tessarollo et al. 1994).
Combination of the NT3 mutation and Bax mutation
dissociates survival from axon outgrowth defects in the NT
signalling mutants. In Bax/NT3 double-mutant animals,
loss of DRG neurons by apoptosis is prevented and neuron
number in L4 ganglia of newborn animals is increased by
~50% as compared with controls (Patel et al. 2003).
Moreover, numerous neurons express parvalbumin even
though they are smaller in diameter than in control animals.
Despite the rescue in neuron number, axon counts in the
soleus nerve of newborn Bax/NT3 double-mutant animals
show a 64% decrease compared with controls and muscle
spindles are absent from the soleus muscle. The absence of
parvalbumin-positive fibres in hindlimb nerves even at E15
and E17 points to the disturbed peripheral projection of
proprioceptors at early developmental stages.
Retrograde labelling by DiI applied to the DRG shows
that central processes of proprioceptors are also affected in
Bax/NT3 double-mutant animals (Patel et al. 2003).
Proprioceptive axons stop in the intermediate zone of the
spinal cord and fail to project to the motor neuron pool in
the ventral spinal cord, as analysed at E15 and E17 and in
newborn animals. This correlates with the absence of
immunoreactivity for the transcription factor Er81 at E15
(Arber et al. 2000). Furthermore, the number of DRG
neurons expressing Er81 mRNA is markedly reduced in
E15 double-mutant animals. In NT3 mutant mice trans-
genically expressing NT3 in muscle under the control of the
myogenin promoter, DRG cell survival and axonal projec-
tion to the ventral spinal cord are rescued (Wright et al.
1997). In addition, Er81 expression is rescued (Patel et al.
2003) indicating that peripheral NT3 sources suffice to
maintain proprioceptor survival, to induce Er81 expression
and to target central proprioceptor projections. In DRG
explants cultured from E11.5 and E12.5 embryos, NT3 but
not NGF rapidly (within 3 h) induces the expression of
Er81 immunoreactivity suggesting the direct regulation of
this transcription factor by NT3 (Patel et al. 2003). Since
ventral spinal cord projection and monosynaptic inputs
from Ia afferents to motoneurons are restored in Er81
mutant mice transgenically expressing NT3 under the
control of the myogenin promoter (Li et al. 2006), NT3
appears to act independently of Er81 on central proprio-
ceptor targeting.
These studies show that NT3, in addition to its survival
action on proprioceptors, is required for the formation of
peripheral and central proprioceptor connections. The
inhibition of axon collateral growth in the grey matter of
embryonic rats after the systemic administration of NT3
(Zhang et al. 1994b) and the absence of central (and
peripheral) Ia projections in newborn mice after transgenic
overexpression of NT3 in the nervous system under the
control of the nestin gene promoter and enhancer regions
(Ringstedt et al. 1997) underlines the importance of the
target muscle as a source of NT3 in the specification of
proprioceptor connectivity.
NTs affect primary afferent connectivity in spinal cord
The NT3 requirement for proprioceptor axons to accom-
plish projection to the ventral horn of the spinal cord
prompts the question as to whether NT3 also affects the
synaptic connections to motoneurons. Embryonic over-
expression of NT3 in muscle of transgenic mice under the
control of a myosin light chain-1 promoter leads to a
substantial increase of monosynaptic excitatory post-
synaptic potential (EPSP) amplitudes recorded extracellu-
larly from ventral roots in neonatal mice (Wang et al. 2007).
Whereas the density of Ia projections to the ventral spinal
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cord appears unaltered, intracellular recordings from moto-
neurons show strong inputs from Ia afferents supplying
unrelated muscles. Postnatal muscular NT3 administration
does not cause these changes showing that embryonic
target-derived NT3 affects the specificity of proprioceptor
connectivity to motoneurons.
In mice with mutational inactivation of the zink finger
transcription factor Egr3, monosynaptic EPSPs in moto-
neurons are severely reduced postnatally (Chen et al. 2002).
Electrical stimulation of muscle nerves elicits EPSPs in
motoneurons at P0; at P2, however, the evoked EPSPs are
lost. Horseradish peroxidase (HRP) application to dorsal
roots at P8 shows that afferent projections to the spinal cord
and termination patterns appear normal. In addition,
afferents are sensitive to mechanical stimulation in the
muscle indicating that the network components are func-
tional but that transmission is disturbed. NT3 injection into
the hindlimb during the first postnatal week maintains
functional sensory-motor connectivity (Chen et al. 2002).
The results show that NT3 derived from peripheral targets
can rescue synaptic transmission from proprioceptors to
motoneurons in the ventral horn of the mutant spinal cord at
postnatal stages.
The subcutaneous injection of NT3 on every other day
during the first postnatal week increases the EPSP
amplitude recorded on P8 intracellularly from antidromi-
cally identified motoneurons in rat (Seebach et al. 1999).
Treatment with trkC-IgG decreases EPSP amplitude just
below statistical significance suggesting that this should be
re-examined by employing more effective suppression of
NT3 signalling. NT3 application, either chronically
(Arvanian et al. 2003) or acutely (Arvanian and Mendell
2001), to the rat spinal cord potentiates synaptic potentials
elicited from dorsal roots. Thus, target-derived and centrally
applied NT3 affects proprioceptor inputs to motoneurons.
The mechanisms appear to differ between embryonic and
postnatal animals.
Application of NGF with an osmotic minipump to
muscle in adult rats for at least 15 days increases the
number of functional A and C fibre inputs from gastrocne-
mius afferents to dorsal horn neurons (Lewin et al. 1992).
Even a single NGF injection into the gastrocnemius soleus
muscle increases the proportion of L4 dorsal horn neurons
responding to stimulation from gastrocnemius soleus nerves
with action potentials within 1 day from 5% to 28%
(Hoheisel et al. 2007). The application of anti-NGF
antiserum in rat from P2–P14 alters the response pattern
of lamina I neurons (Lewin and Mendell 1996). Whereas
90% of the dorsal horn neurons in control animals are
noxious-specific, only 45% behave noxious-specifically in
anti-NGF antiserum-treated animals, 30% show a wide
dynamic range behaviour and 23% have no cutaneous
receptive field. Thus, dorsal horn connectivity appears to be
strongly affected by NGF signalling. Since Aδ afferent
populations are strongly altered by the anti-NGF antiserum
treatment, it is unclear whether the change in dorsal horn
excitability is attributable to anatomical or physiological
alterations. Analysis of double-mutant mice deficient for
Bax and NGF signalling may clarify this issue.
At adult stages, the excitabiltiy of spinal dorsal horn
neurons is upregulated during inflammation in a NGF-
dependent manner (for reviews, see Thompson et al. 1999;
McMahon and Jones 2004). The central sensitization is
partially prevented by the antagonism of BDNF, which is
expressed in an NGF-sensitive mode in small-diameter
nociceptors and acts as a neuromodulator in the dorsal horn.
The data show that NTs alter spinal cord transmission of
primary afferent impulses. Even though the cellular and
molecular mechanisms remain to be analysed, the findings
demonstrate that NTs crucially affect connectivity at the
first central relay station of primary afferent neurons.
Summary
trk expression
The distribution of trkA, trkB and trkC and the patterns of
neuron loss in the respective mutant animals demonstrate
their expression and requirement for survival in well-
segregated populations of DRG neurons (for a review, see
Snider 1994; Snider and Silos-Santiago 1996). Nociceptors
depend on trkA, whereas proprioceptors require trkC
signalling. The neuron populations depending on trkB
signalling are less well described.
A correlation of trk expression and sensory targets has
been performed in adult rats. trkA-positive units constitute
the majority of trk-expressing DRG neurons innervating
skin, whereas the bulk of neurons innervating muscle
expresses trkC. trkB expression is found in a small
proportion of DRG neurons in the cutaneous saphenous
nerve and almost all of the DRG neurons projecting in the
visceral pelvic nerve. Together with a high percentage of
trkA-positive fibres in the pelvic nerve, this shows that trk
receptors may be coexpressed in selected DRG neuron
populations.
trkA-expressing DRG neurons in rat have been charac-
terized electrophysiologically. The large majority (~80%) of
skin nociceptors are trkA-positive. The detection of trkA in
some apparently non-nociceptive LTMR with Aδ and C
fibre conduction velocities shows, however, that trkA
expression in DRG is not restricted to pain detectors.
The developmental profile of trk expression has been
analysed in detail in mouse embryos. trkC expression is
detectable early at E10 and, by E11, almost all cells are
intensely trkC-positive. Thereafter, their number decreases,
whereas total neuron number increases such that trkC-
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positive cells amount to less than 10% at E13. The first
trkA-positive cells are reported at E10.5 in mouse DRG and
their number and percentage increase thereafter. At E11,
approximately 20% of neurons express trkA and, by E13,
the proportion has increased to 80%. Moreover, in the chick
embryo, a similar succession for trk receptor expression is
observed and the expression of trkC in mitotically active
precursors has been shown. In addition, the coexpression of
trk receptors during sensory neurogenesis has been
quantified in chick embryos. Apparently all of the trkA-
or trkB-positive cells transiently coexpress trkC at early
developmental stages.
Survival
Treatment of avian and mammalian embryos with antisera
against NGF and NT3 demonstrates the requirement for
these NTs for nociceptor and proprioceptor survival,
respectively. Analysis of mice mutant for NTs and their
high-affinity receptors provides details of their develop-
mental role (for reviews, see Snider 1994; Snider and
Silos-Santiago 1996).
The mutation of trk receptors leads to the loss of distinct
neuron populations by cell death. Mutational inactivation of
trkA leads to the loss of nociceptors by increased apoptosis
around E13.5 in mouse embryos. Mutational inactivation of
trkC results in the loss of proprioceptors by apoptosis
around E11. The time course of cell loss in trkB mutant
mice is less well documented. Combinatorial trk receptor
mutations indicate that a subset of neurons requires trkA
and trkB signalling for survival, since cell loss in double-
mutants is not additive compared with single mutants
(Minichiello et al. 1995). These neurons may be visceral
afferents coexpressing trkA and trkB (McMahon et al.
1994). In double-mutants of trkB and trkC, the lack of a
parvalbumin-positive neuron population with projections to
the intermediate spinal cord layers has been documented, in
addition to the absence of proprioceptive afferents
(Silos-Santiago et al. 1997).
Neuron loss in NGF mutants occurs embryonically with
a time course similar to that in trkA mutants. Moreover, for
BDNF mutants, embryonic cell loss similar to that in
mutants of its high-affinity receptor trkB has been reported.
For NT4, which also signals via trkB, altered neuron
numbers have been documented postnatally. In NT3 mutant
animals, neuron loss occurs embryonically and postnatally.
Even at early embryonic stages, cell loss exceeds that
observed in trkC mutants. Complete loss of neurons with
proprioceptor markers and a reduction in the number of
neurons showing nociceptor markers in newborn animals
(Airaksinen and Meyer 1996) demonstrates the obligatory
requirement for NT3 in proprioceptor development and an
effect on the size of other sensory neuron populations.
Early trkC-expressing cells are completely lost in NT3
mutant animals and neurons positive for trkA and trkB are
lost to the same extent as the reduction in total neuron
population during embryonic development. Postnatally,
NT3 is required for the survival of a cutaneous mechano-
receptor population.
Neurite outgrowth and spinal cord connectivity
Both the survival-promoting and the neurite-promoting
activity of NGF were apparent from the outset. With the
intercrossing of NT mutants with mutants for the proapop-
totic Bax gene, the analysis of neurite outgrowth defects
independent of neuronal cell death has become possible.
This kind of analysis has demonstrated that NGF and NT3
are required in the respective afferent subpopulations for
peripheral target innervation. Loss of PGP9.5-positive
fibres in the cutaneous saphenous nerve and hindlimb skin
of trkA/Bax double-mutants and of trkA-positive axons in
the distal hindlimb of NGF/Bax double-mutants has
demonstrated the NGF requirement for neurite outgrowth
to cutaneous targets. The absence of parvalbumin-positive
fibres in hindlimb nerves and the decreased axon counts in
the soleus nerve of newborn NT3/Bax double-mutant
animals demonstrate the NT3 requirement for the peripheral
projection of proprioceptors.
Whereas the peripheral projections of both NGF- and
NT3-sensitive afferents require NT signalling, central
projections differ in sensitivity. Projection appears normal
and trkA-immunoreactive fibres are found in the superficial
dorsal horn of NGF/Bax double-mutants as in the wildtype.
In contrast, proprioceptive axons stop in the intermediate
zone of the spinal cord and fail to project to the motor
neuron pool in the ventral spinal cord in NT3/Bax double-
mutant animals. This shows that both types of fibres can
enter the spinal cord in the absence of signalling by the
respective NT; they differ, however, in the NT sensitivity of
access to the final target. Muscle-derived NT3 allows
axonal elongation from the intermediate spinal cord to the
ventrally located motoneurons. In addition, the administra-
tion of NT3 promotes functional connectivity between Ia
afferents and motoneurons postnatally. Thus, NT3 acts as
target-derived factor to shape proprioceptor network con-
nectivity. NGF affects connectivity in the dorsal horn of the
spinal cord. The mechanisms by which NT exerts its effects
and the developmental regulation of these mechanisms
remain unknown.
Afferent properties
On the basis of the observation of lasting hyperalgesia
following NGF administration, the alteration of the receptive
properties of DRG neurons by NTs in vivo has been
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characterized in some detail. Two types of changes are of
interest: modifications in the threshold and response ampli-
tude of existing receptive qualities and the acquisition of new
response qualities. These may require different transduction
mechanisms, in particular different means of transcriptional
and posttranslational regulation and probably differ in their
consequences for physiological classification.
The first category includes the reduction in mechanical
threshold of Aδ HTMR nociceptors in rat and Aδ AM
nociceptors in mouse after excess availability of NGF.
Reduction of BDNF levels in mice results in an increase in
mechanical threshold of SAM, demonstrating that different
NTs affect the response threshold in different sensory
neuron populations.
The second category of alterations includes changes in
the proportion of heat-responsive C fibre nociceptors with
NGF availability in rat and mice. In this case, mechano-
sensitive C-M nociceptors change to mechanoheat-sensitive
C-MH nociceptors.
The increase in abundance of D hair afferents in rats
injected with anti-NGF antibodies appears to be of a
different quality. The parallel decrease in the abundance
of Aδ HTMR units provokes the question as to whether
NGF availability leads to phenotypic shifts between
nociceptors and LTMR. Different from expectation, no
corresponding increase in the percentage of HTMRs is
found after NGF injection in rats. In mice overexpressing
NGF in skin, however, the prevalence of mechanosensitive
Aδ AM nociceptors in saphenous nerve increases from 65%
in control to 97% in transgenic animals in parallel to an
almost complete reduction in the proportion of D hair
afferents.
The mechanisms underlying these NT-induced altera-
tions in afferent properties remain to be determined. An
understanding of the properties and regulation of sensory
transducers will help to explain the changes in sensitivity to
mechanical and thermal stimuli. The mutual regulation of
nociceptors and D hair afferents may also include the
rerouting of sensory fibres in the target tissue and might
involve profound differentiation mechanisms.
Regulation of channel expression
TRP family channels, Deg/ENaC family channels and
voltage-dependent sodium channels are involved in trans-
duction and signal propagation in sensory neurons. Regu-
lation by NTs has been demonstrated for these channel
classes.
The proportion of TRPV1- and TRPM8-mRNA-
expressing neurons is reduced in DRG of newborn NGF/
Bax double-mutant mice by 30% and 80%, respectively,
demonstrating the regulation of TRP channel expression by
NGF during embryogenesis. Long-lasting regulation of heat
sensitivity in nociceptors by postnatal NGF administration
in rats indicates that TRP channel expression is also
regulated by NGF after birth, even though the molecular
changes have not yet been characterized. In adult rats,
TRPV1 and TRPA1, but not TRPM8, expression in DRG is
increased during inflammation. The blockage of this
increase by anti-NGF antibodies demonstrates that NGF
also affects TRP channel expression in adult DRG neurons.
Thus, TRPV1 expression appears sensitive to NGF signal-
ling at all developmental stages and in vitro results suggest
that the effects may be direct. The role of NGF in the
maintenance of physiological expression levels in postnatal
animals, other than induction by inflammatory processes,
has not been analysed, however. In addition to alterations in
mRNA and protein expression, rapid posttranslational
regulation occurs in adult animals and may entail the
phosphorylation of TRP channel protein and transport to
the plasmamembrane.
In BDNF mutants, ASIC2 expression is reduced in
parallel to a reduction in mechanosensitivity of slowly
adapting low-threshold receptors (SAM). Culture experi-
ments indicate that BDNF directly affects neuronal expres-
sion of a putative mechanosensor and suggest the need for
further developmental analysis.
Transgenic NGF overexpression in skin increases the
expression of voltage-gated sodium channels. The mRNA
levels for Nav1.8/SNS sodium channels in DRG neurons
are enhanced in DRG of transgenic animals. Protein levels
in A fibre nociceptors correlate with trkA expression in
wildtype animals. The regulation of sodium channel
expression by NTs during development remains to be
characterized in more detail.
Lineage specification
Analysis of NGF/Bax and trkA/Bax double-mutant mice
has shown that trkA signalling is required for the
differentiation of peptidergic nociceptors. In DRG of
newborn trkA/Bax double-mutant mice, SP and CGRP,
the population-specifying markers of peptidergic noci-
ceptors, are undetectable, even though cell death is
prevented by the Bax mutation. The induction of CGRP
expression in cultures of DRG explants from Bax single
mutants shows that NGF may induce neuropeptide
expression with a normal time schedule. This suggests
that NGF supports peptidergic differentiation in vivo
directly but does not definitively establish that other
signalling systems are not required. The presence of a
large number of CGRP-negative neurons in NGF-treated
cultures from Bax mutant mice and in dissociated
cultures from rat DRG neurons at E12.5 and E14.5
provokes the question of whether neurons are prespeci-
fied to a peptidergic or non-peptidergic phenotype.
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In NGF/Bax double-mutants, only a few strong ret-
positive neurons are present at P0; these are trkA-negative.
This observation shows that NGF signalling is also
involved in the differentiation of those ret-expressing
neurons that develop from trkA-expressing cells and give
rise to non-peptidergic nociceptors.
The trk receptors themselves are important lineage
markers expressed early during DRG development. Be-
cause of their coexpression with trkC during the initiation
of trkA or trkB expression, which amounts to 100% of the
respective cells in chick DRG, the precise onset of
differentiation is not well specified by the trk pattern. trkC
expression is restricted to a small subpopulation of DRG
neurons only with ongoing development. The mechanism
underlying this process is not as yet known. Moreover, the
signals involved in the acquisition of trkA expression in the
vast majority of DRG neurons during midembryonic
development remain to be determined. In newborn NGF/
Bax double-mutant mice, trkA expression is rescued (Patel
et al. 2000) and, in rats injected with NGF or anti-NGF
antiserum postnatally for 2 weeks, the proportion of trkA-
positive neurons is not altered (Molliver and Snider 1997).
The data indicate that NGF is not required for trkA
expression. Furthermore, the initiation of trkA expression
appears normal in NT3 mutant mice.
An effect on the trk expression pattern in DRG has been
reported for NT4. Mutation of NT4 reduces the proportion
of trkB-expressing and increases that of trkC-expressing
DRG neurons in newborn mice (Liebl et al. 2000). In adult
NT4-overexpressing animals, the opposite alterations are
observed (Krimm et al. 2006). The mechanism of this effect
still needs to be resolved.
In mice in which trkA is replaced by the coding
sequence for trkC, 600–700 neurons in L4 and L5 ganglia
express the proprioceptor marker parvalbumin as compared
with 200–500 in the wildtype (Moqrich et al. 2004). The
authors conclude that 8% of the presumptive trkA neurons
switch to a proprioceptive phenotype. This study may
present the most direct evidence for lineage specification by
NT signalling. The switch, however, affects only a small
percentage of the neurons with altered trk expression.
Because of the restricted size of the affected population and
its unknown fate in wildtype animals, the results are
difficult to judge.
Functional analysis of NT signalling in the sympathetic
system
The discovery of a dramatic hypertrophy of sympathetic
ganglia in chick (Levi-Montalcini and Hamburger 1951)
and several mammalian species (Levi-Montalcini and
Booker 1960a, b) induced by NGF can be considered as
the key step for the molecular analysis of neuronal
development. The correlation of NGF levels in rat organs
with sympathetic innervation density (Korsching and
Thoenen 1983) and the developmental time course of
NGF availability (Korsching and Thoenen 1988) strongly
supported the concept that NGF production in target organs
determines the density of sympathetic innervation.
The daily injection of purified NGF in postnatal mice
results in a two- to three-fold increase in the size and cell
number of thoracic sympathetic ganglia (Levi-Montalcini
and Booker 1960a) and SCG (Black et al. 1972).
Conversely, the application of anti-NGF antiserum leads
to a massive loss of neurons from the SCG in postnatal
mice and other mammalian species (Levi-Montalcini and
Booker 1960b; Angeletti et al. 1972): cell counts in
experimental animals analysed between P20 and P120
amount to ~1% of the control. Similarly, anti-NGF injection
in newborn rats, rabbits and cats leads to more than an 80%
reduction in sympathetic ganglion cell counts.
The effects of anti-NGF antiserum differ between para-
vertebral and prevertebral sympathetic ganglia. Treatment of
newborn rats for 5 days after birth results in the massive
atrophy of SCG and stellate ganglia (STG), whereas mesen-
teric ganglia appear normal in size and structure (Vogt 1964;
Zaimis et al. 1965). Moreover, retrograde labelling of
sympathetic neurons in rats injected neonatally with anti-
NGF antiserum show a smaller loss of neurons in mesenteric
compared with other sympathetic ganglia (Hill et al. 1985).
The SCG and other sympathetic ganglia are affected not
only by postnatal, but also by prenatal application of the
antiserum (Klingman and Klingman 1967). Injection of
antiserum into pregnant mice at days 15, 16 and 17 leads to
~80% cell loss in STG and SCG of progeny analysed
postnatally. Conversely, transuterine injection of NGF in
embryonic mice increases the number of catecholaminergic
neurons (Kessler and Black 1980a).
NGF dependence is less acute in adult mice. Repeated
injection of NGF leads to an increase in the size of
sympathetic ganglia but not in neuron number in STG and
SCG (Levi-Montalcini and Booker 1960a). Daily injections
of anti-NGF antiserum for five consecutive days results in a
marked size reduction of the sympathetic chain; this is only
partly attributable to cell death (Angeletti et al. 1971a).
Instead, reversible changes in neuron size appear to be
involved. The long-term exposure to anti-NGF antibodies by
injection into mice for several weeks, however, leads
to a significant reduction of the cell number in SCG
(Levi-Montalcini and Booker 1960b; Ruit et al. 1990). The
cell loss develops progressively and depends on antibody
titer. In animals treated with high titer antisera, 70% cell loss
has been reported after daily application for 1–3 months.
Analysis in mutant mice has confirmed the central role
of NGF for sympathetic neuron survival and specified the
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timing of the requirement for NGF during embryonic
development. The tight correlation of deficiencies in the
sympathetic neuron number of NGF and trkA mutant mice
contrasts with the differences in neuron losses of NT3 and
trkC mutant mice, as discussed below. The findings
demonstrate that NGF acts via trkA, whereas NT3 is not
restricted to signalling via trkC in sympathetic neuron
differentiation. No significant change in SCG size and no
decrease in neuronal counts have been observed in BDNF
mutant mice (Ernfors et al. 1994a; Jones et al. 1994).
Rather, neuron number is slightly but not significantly
increased (114% of wildtype; Ernfors et al. 1994a).
Similarly, no effect on the SCG has been observed in trkB
mutant mice (Fagan et al. 1996). This, in agreement with
trk expression patterns, shows that signalling through trkA
and trkC, but not trkB, is important for the development of
the majority of sympathetic neurons.
Analysis of mutant mice demonstrates the requirement
of NGF signaling for sympathetic neuron survival
during the third embryonic week
Mutation of the gene coding for NGF results in dramatic cell
losses in sympathetic ganglia. The SCG have disappeared by
P14 (Crowley et al. 1994), with pyknotic nuclei at postnatal
stages documenting cell death. Even in newborn animals, the
majority of cells is lost in SCG and STG (Francis et al. 1999;
Glebova and Ginty 2004). Whereas no significant cell loss is
observed at E15.5 and E16.5, reduced numbers of ganglion
cells are detected from E17.5 onwards. Similar to the
situation in NGF mutant mice, the loss of functional high-
affinity NGF receptors by mutation of the trkA kinase
domain leads to a severe reduction in the size of SCG and
other sympathetic ganglia (Smeyne et al. 1994). Whereas no
obvious difference has been observed between trkA mutant
and wildtype SCG at E11.5 and E13.5, a reduction in cell
number has been reported at E15.5 (15%) and E17.5 (35%;
Fagan et al. 1996). During these developmental stages,
increased numbers of pyknotic nuclei indicate excessive cell
death. Thus, mutation of NGF or its high-affinity receptor
trkA lead to comparable amounts of ganglion cell loss by
cell death starting during the third week of embryonic
development.
NT3 availability affects sympathetic ganglion
cell number at developmental stages when neurons
are also NGF-dependent
A reduction of sympathetic ganglion cell number also
occurs in NT3 mutant mice and is reported to be 35%–50%
for newborn SCG (Farinas et al. 1994; Ernfors et al. 1994b;
Tessarollo et al. 1997; Francis et al. 1999) and 27%–46%
for STG (Francis et al. 1999; Story et al. 2000). In contrast,
mutation of the high-affinity receptor for NT3, trkC, does
not lead to alterations in SCG cell numbers at E13.5–P9
(Fagan et al. 1996; Tessarollo et al. 1997), indicating that
NT3 can act via trkA during sympathetic development.
An early study reporting neuron loss in SCG in NT3
mutants between E11 and E17 attributable to increased
apoptosis (ElShamy et al. 1996) has not been confirmed by
other laboratories. In three laboratories, no alteration in
ganglion cell number has been observed at E15.5 and E16
(Wyatt et al. 1997; Francis et al. 1999; Kuruvilla et al.
2004) and the number of pyknotic cells is unaltered (Wyatt
et al. 1997; Francis et al. 1999). Rather, significant cell loss
is detected from E17.5 onwards and, at E17.5–P1,
significantly more pyknotic cells are found in mutant
SCG (Wyatt et al. 1997; Francis et al. 1999).
In compartmentalized cultures of sympathetic neurons
from newborn rat, NT3 supports survival only when
applied to cell bodies, not when given to distal axons
(Kuruvilla et al. 2004). In contrast, NGF supports survival
when applied to cell bodies or to axons. The results indicate
that NT3 in vivo may not be required as a survival factor
per se but promotes the access of growing nerve fibres to
target-derived NGF for survival (see below). This is in
accordance with the relatively late onset of cell death that
coincides with the stage of NGF dependence in NT3 mutant
mice (Francis et al. 1999). Further support comes from the
finding that sympathetic neuron loss in SCG of E17.5
NGF-deficient mice is not exacerbated by mutation of NT3
(Francis et al. 1999).
NGF availability promotes peripheral innervation
Postnatal injection of NGF in mice results in an increased
density of fibres in target organs and innervation of
normally non-innervated tissues (Levi-Montalcini and
Booker 1960a; Olson 1967). Correspondingly, neonatal
rats injected with NGF show a two-fold increase of
noradrenalin in the heart (Kornblum and Johnson 1982).
Six daily NGF injections in adult mice result in increased
catecholamine fluorescence intensity and density of the
nerve terminal plexus in various sympathetic target tissues
(Bjerre et al. 1975). Two months after this treatment, these
effects have almost totally disappeared. The authors
conclude that NGF reversibly stimulates collateral sprout-
ing in sympathetic target tissues.
Conversely, prenatal or postnatal injection of anti-NGF
antiserum in mice leads to reduced catecholamine levels in
sympathetic target tissues (Klingman and Klingman 1967).
The reduction of catecholamine levels in target tissues after
antiserum injection in postnatal rats correlates with the
reduction of the ability of these tissues to take up
radiolabelled noradrenalin (Zaimis et al. 1965). Differences
in the decrease in noradrenalin uptake between various
370 Cell Tissue Res (2009) 336:349–384
target tissues (Zaimis et al. 1965; Iversen et al. 1965) are in
accordance with the different losses of sympathetic neurons
across prevertebral and paravertebral sympathetic ganglia
upon treatment with anti-NGF antiserum. Application of
antiserum on five consecutive days in adult mice leads to a
reduction in the noradrenalin content of various target
tissues; this recovers partially within weeks after cessation
of the antibody treatment (Angeletti et al. 1971a).
Thus, NGF application increases sympathetic fibre
density in target organs and the antiserum reduces bio-
chemical indicators of sympathetic target innervation. Upon
electron-microscopical examination of sympathetic ganglia
in NGF-treated newborn or adult mice, the most prominent
feature is a massive increase in neurofilaments and neuro-
tubuli (Angeletti et al. 1971b). This observation together
with the analysis of the regulation of Tα1 tubulin
expression shows that NGF may affect the availability of
neuron-specific cytoskeletal components.
Daily NGF injection from P2 to P11 in rats prevents the
decrease in Tα1 tubulin mRNA levels in SCG observed by
Northern blotting in untreated animals during the
corresponding developmental period (Mathew and Miller
1990). Culture studies with dissociated neurons from
newborn rat SCG show that the increase in Tα1 tubulin
mRNA levels depends on the NGF concentration with a
time course different from that of TH induction (Ma et al.
1992; see also below). In PC12 cells, the NGF-induced
increase in α tubulin mRNA levels precedes neurite
extension (for discussion, see Mathew and Miller 1990)
and is attributable to an elevation of transcription rate,
different from the increase in steady state TH mRNA levels
(Miller et al. 1991). The authors conclude that the induction
of Tα1 tubulin reflects a generalized growth response and
correlates with collateral sprouting in the terminal arbour.
Transgenic overexpression confirms the role of NTs
in sympathetic neuron survival and target innervation
Experiments involving the administration of exogenous
NGF have been extended by the overexpression of NGF,
via a K14 keratin promoter, in the epidermis of transgenic
animals: SCG neuron number is increased 2.7-fold as
analysed postnatally (Davis et al. 1996) and sympathetic
innervation in the skin is increased, as shown by IHC for
TH (Albers et al. 1994). Sympathetic innervation of target
organs has been analysed in detail in footpads (Guidry et al.
1998). The temporal sequence of footpad innervation is not
affected in the NGF-overexpressing animals. Axon parti-
tioning in the target tissues, however, is disrupted. Sweat
glands and blood vessels, the two sympathetic targets in
footpads of wildtype animals, lack substantial innervation
in transgenic animals. Instead, a dense plexus of catechol-
aminergic sympathetic fibres appears in the dermis.
Similarly, in whisker-pad skin of transgenic mice, TH-
immunoreactive fibres are found throughout the dermis and
adjacent to the epidermis (Davis et al. 1996). In contrast, in
control mice, TH-positive fibres are found in the dermis
primarily associated with blood vessels.
In transgenic mice expressing BDNF under the control
of the α-myosin heavy chain promoter, enhanced BDNF
protein levels are detected in skin, where mRNA is found in
the subcutaneous muscle layer, not in the arrector pili
muscle or the vascular tunica muscularis (Botchkarev et al.
1998). A substantial TH-positive hyperinnervation of
arrector pili muscle and surrounding dermis is evident in
these animals. Whether this affects the minor trkB-positive
population of sympathetic neurons or is mediated by the
low-affinity NT receptor p75 remains to be resolved.
Expression of a NT3 transgene under the control of a
human K14 keratin promoter in basal skin keratinocytes in
mice results in a 32% increase in the number of SCG
neurons as compared with control animals (Albers et al.
1996). No data on sympathetic target innervation are
presented in this study, however.
Analysis of mutant mice shows effects of NGF and NT3
at different stages of sympathetic neurite outgrowth
In trkA mutant mice, the initial axon outgrowth from the
SCG at E13.5, as analysed by IHC for TH, does not differ
from that in wildtype animals (Fagan et al. 1996). At later
stages, however, sympathetic target innervation is compro-
mised. The submaxillary gland, a distant target that first
receives TH-positive fibres in wildtype animals at E15.5,
shows no significant TH immunoreactivity in trkA mutants
throughout embryonic development. In NGF-deficient
mice, a variable phenotype of salivary gland innervation
has been reported at E17.5, with TH-positive fibres being
detected in three out of five mutant animals and with two
animals lacking salivary gland innervation entirely (Francis
et al. 1999). The requirement for NT signalling in neurite
outgrowth has been analysed in more detail by whole-
mount IHC for TH in mice double-mutant for Bax and
NGF (Glebova and Ginty 2004). In these animals, NGF is
not required for sympathetic neuron survival such that
neurite outgrowth is not compromised by cell death. At
E16.5, proximal projections from the SCG, STG and
sympathetic chain ganglia appear grossly normal. In
neonatal NGF/Bax double-mutant mice, sympathetic target
innervation is absent in certain organs such as the salivary
glands, is strongly reduced in others such as the heart, is
slightly reduced in a few organs such as the stomach and
kidneys and is not reduced in some structures such as the
trachea (Glebova and Ginty 2004). Interestingly, NGF is
not required for axon extension along arteries; the NGF
requirement may become apparent when sympathetic fibres
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leave arteries to innervate organ parenchyma as observed in
the spleen.
In NT3 mutant mice, unlike NGF mutant animals,
proximal axon extension along the vasculature around the
SCG, as analysed by whole-mount IHC for TH, is impaired
even at E15.5 when neuron numbers in the ganglion are not
affected (Kuruvilla et al. 2004). In addition, STG projec-
tions to the heart at this stage are shorter in NT3 mutants as
compared with wildtype littermates. At later stages,
sympathetic end-organ innervation is strongly compromised
in the absence of NT3. At P0.5, the hearts of NT3/Bax
double-mutant animals show markedly reduced levels of
sympathetic innervation as compared with Bax mutant mice
(Kuruvilla et al. 2004). Two other studies, however, report
normal innervation of NT3 mutant hearts by TH-positive
sympathetic fibres at birth (Story et al. 2000) and at P15
(ElShamy et al. 1996). Cardiac noradrenalin concentrations
are found to be equivalent among wildtype and NT3 mutant
mice at birth but differences become apparent with age
(Story et al. 2000). NT3 elimination affects the innervation
of the various targets differently. Staining of sympathetic
nerve fibres with IHC for TH and glyoxylic acid fluores-
cence at P15 shows a similar to normal nerve fibre ground
plexus in the NT3 mutant iris and submandibular gland but
the complete absence of sympathetic innervation in the
pineal gland and external ear (ElShamy et al. 1996). In the
pineal gland and external ear, the absence of TH-positive
sympathetic nerve fibres is observed at all stages examined,
in accordance with a requirement for NT3 during early
neurite outgrowth.
In vitro studies suggest an NGF effect on neuron-target
connectivity
In cultures of SCG neurons and ventricular myocytes from
neonatal rat, NGF perfusion leads to an acute increase in
the beating rate of myocytes (Lockhart et al. 1997). In
addition, long-term effects are observed in cocultures
grown for 3 days with two NGF concentrations that both
support neuronal survival. The myocyte response to
neuronal stimulation is greater in 50 ng/ml NGF than in
5 ng/ml NGF and the connection probability is increased.
No difference in basic electrophysiological features such as
the resting membrane potential is observed but the
proportion of myocytes with dense neuritic contacts varies
with NGF (Lockhart et al. 2000). The number of SV2-
containing neurite endings is increased at higher NGF
concentrations and by interaction with mature myocytes. A
molecular analysis of the promotion of contact formation
between sympathetic neurons and their targets will be of
great interest. In cultured sympathetic neurons of young
chick embryos, NGF directly affects the splicing of
neurexin I (Patzke and Ernsberger 2000). This presynaptic
protein binds to neuroligins and associates with calcium
channels and, thus, may play a crucial role in synapse
organization and function.
NGF promotes dendritic growth and preganglionic
innervation
Daily subcutaneous injection of NGF in newborn rats
for 1 or 2 weeks results in an increase in the number of
primary dendrites, the total dendritic length and the
extent of dendrite branching in SCG neurons as
revealed by intracellular staining of individual SCG
cells after filling with HRP or Lucifer yellow (Snider
1988; Ruit and Snider 1991). Conversely, treatment with
anti-NGF antiserum for the first three postnatal weeks
reduces the number of primary dendrites, the total
dendritic length and the extent of dendrite branching
(Ruit and Snider 1991). In adult mice, alteration of NGF
levels affects total dendritic length and the number of
dendrite branch points, but not the number of primary
dendrites (Ruit et al. 1990). In cultures of SCG neurons
from perinatal rats, the NGF concentration affects the
number of dendrites per neuron and the percentage of
neurons with dendrites (Lein et al. 1995). In this latter
study, cells were supplemented with saturating concen-
trations of bone morphogenetic protein 4 in addition to
variable concentrations of NGF. Since cell number is
affected in a similar way as dendritic growth, NGF effects
on neuron survival and process outgrowth cannot be
readily separated.
Microelectrode intracellular recordings on sympathetic
neurons from guinea-pigs treated with anti-NGF antiserum
demonstrate an NGF requirement for sympathetic neuron
connectivity (Njå and Purves 1978). SCG isolated with
attached preganglionic and postganglionic nerves at 5–
8 days after the last of four daily injections of anti-NGF
antiserum show abnormal postsynaptic potentials with low
amplitude after stimulation of preganglionic nerve trunks.
The mean number of synapses per unit area is reduced by
48% in treated ganglia and the area of presynaptic profiles
is smaller as analysed by electron microscopy. Ganglia in
the treated animals are of normal size and neuron number,
showing that the effect on synaptic transmission is
independent of neuronal survival and that the antiserum
doses were too low or the application too short to induce
cell death. No difference in the effect has been described
upon the grouping of experimental animals by age between
P4 and sexual maturity. The application of exogenous NGF,
however, has no effect on the function or number of
synapses (Njå and Purves 1978). This indicates that the
endogenous supply is saturating for connectivity in surviv-
ing neurons but might also be attributable to the experi-
mental set-up.
372 Cell Tissue Res (2009) 336:349–384
NGF regulates ionic currents in sympathetic neurons
Injection of NGF and anti-NGF antibodies into adult
leopard frogs affects the calcium conductances recorded
from sympathetic ganglion B cells (Lei et al. 1997).
Recordings from dissociated cells acutely isolated on days
9 or 10 from animals that had received subcutaneous
injections every other day on days 1–7 show a 56%
increase of the whole-cell barium current upon NGF
injection and a 20% decrease of the current upon antibody
injection. In cell culture, the current decreases over a 15-
day culture period; this decrease can be prevented by NGF.
Both N-type and L-type currents are affected. Under the
same in vitro conditions, TTX-sensitive and TTXR sodium
currents are also increased by NGF (Lei et al. 2001; Ford et
al. 2008), although delayed rectifier and M-type potassium
currents remain unaffected.
However, NGF effects on potassium conductances have
been shown in avian and mammalian sympathetic neurons
in vitro. In lumbar sympathetic neurons taken from E13
chick and cultured for 5 days, NGF increases calcium-
dependent potassium currents (IKCa) as analysed by whole-
cell recordings (Raucher and Dryer 1995). The bimodal
distribution of the current densities in NGF-treated cultures,
in which half of the neurons show large current amplitude,
indicates the presence of different neuronal subpopulations.
Whether NGF contributes to the increased survival of a
neuronal subpopulation with a high IKCa current density or
induces IKCa currents in an existing subpopulation of
neurons is unclear from this study. In 2– to 4-day cultures
of neonatal rat SCG neurons supplemented with 5 ng/ml
NGF for survival, acute treatment with 50 ng/ml NGF
affects neuronal excitability and diverse potassium currents
(Luther and Birren 2006). NGF increases the current
threshold for action potential initiation, hyperpolarizes the
resting membrane potential, reduces the number of spikes
per stimulus but increases the firing frequency resulting in a
phasic discharge. Again the data show a bimodal distribu-
tion indicating multiple neuron groups that differ in their
firing properties and NGF response. The isolation of the
calcium-independent potassium current by TTX and cobalt
chloride shows that the amplitude of all three kinetically
separated potassium currents activated upon depolarizing
voltage commands are decreased by NGF. Moreover,
calcium-dependent potassium currents measured from tail
currents are significantly smaller after an NGF challenge.
Different from sympathetic neurons from chick embryos,
NGF decreases IKCa in neonatal rat SCG cells.
In SCG neurons of 4- to 6-week-old rats, acute NGF
application results in a rapid inhibition of M/KCNQ
currents (Jia et al. 2008). Cells have been recorded in a
whole-cell patch and perforated whole-cell patch configu-
ration within 48 h in culture in the absence of NGF
followed by NGF supplementation at 20 ng/ml for 2 min.
The excitability of tonic neurons, but not of phasic neurons,
is increased by NGF and the spike number but not the
resting potential is increased in tonic neurons. M/KCNQ
currents, pharmacologically separated by sensitivity to
linopiridine, are inhibited by the NGF challenge. Current
inhibition follows immediately after NGF addition with a
time constant of single exponential decay at ~100 s. The
results indicate a rapid posttranslational regulation resulting
in a reduced single channel open probability. Inhibition
starts at 0.05 ng/ml NGF and reaches a maximum at 20 ng/
ml, strongly suggesting signalling via the high-affinity NGF
receptor trkA.
These studies show that NGF can regulate calcium
currents in frog sympathetic neurons in vivo. The regula-
tion of calcium and sodium conductances in vitro indicates
that NGF directly acts on the neurons. In addition, NGF
affects diverse potassium conductances in avian and
mammalian sympathetic neurons in vitro. The way in
which the potassium currents, their differential expression
in sympathetic neuron subpopulations and their control of
neuronal excitability are regulated by NGF throughout
development in vivo is currently unclear. Whether NGF
regulates sodium and calcium conductances in amniote
sympathetic neurons is also of interest.
Alteration of NGF availability affects noradrenergic
properties in sympathetic neurons
NGF injection into newborn rats augments noradrenergic
transmitter properties. Daily injections for 5 days to 3 weeks
result in a specific increase in TH and DBH activity
(Thoenen et al. 1971; Hendry 1975). 3,4-Dioxyphenylala-
nine decarboxylase (DDC) and monoamine oxidase in-
crease to the same extent as total protein. Even a single
injection of NGF at doses below those required for an
increase in ganglionic protein content elevates TH activity
in rat SCG (Stöckel et al. 1974; Kornblum and Johnson
1982). Conversely, a single anti-NGF antiserum injection
into newborn rat decreases the activity of TH, DBH and
monoamine oxidase (Angeletti et al. 1972). Moreover, in
newborn mice, single doses of NGF or anti-NGF injection
increase or decrease, respectively, TH activity in SCG
(Hendry and Iversen 1971; Hendry 1973).
The TH response to NGF in SCG changes with age. The
increase in TH activity after a single NGF injection in adult
rat SCG is smaller than that in newborn animals (Otten et
al. 1977). Upon single injection of anti-NGF at P2, a
marked irreversible drop of TH, DBH and DDC activities
occurs while a single injection at P30 results in smaller
enzyme reductions which are completely reversible
(Goedert et al. 1978; compare Hendry and Iversen 1971).
Immunization of adult rats results in decreased total enzyme
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activities for TH, DBH, and DDC in SCG; these partially
recover 7 months after the last booster when antibody titers
have decreased (Otten et al. 1979).
Transuterine injection of NGF in mouse embryos
increases TH activity in SCG at all gestational stages
analysed (Kessler and Black 1980a). This results from an
increase in the number of catecholaminergic neurons and an
increased activity per neuron as analysed at E17 after
injection at E15. Anti-NGF injection at E12 leads to a TH
reduction with incomplete recovery, whereas treatment at
E15 results in a marked TH reduction that does not recover
within a 5-week analysis period.
Cultures of sympathetic neurons have been instrumental
for analysing the mechanism of TH induction by NGF.
Explant cultures of SCG from adult rats show an increase
of specific TH activity by NGF during a 2-day culture
period; this is attributable to increased enzyme protein
synthesis as shown by [3H]leucine incorporation (Max et al.
1978). Since the induction is not inhibited by the RNA
synthesis blockers α-amanitin or actinomycin D in cultures
of sympathetic neurons at various developmental stages
(Rohrer et al. 1978; Hefti et al. 1982), a posttranscriptional
mechanism must be responsible. Surprisingly, TH mRNA
levels as analysed by Northern blot increase specifically
and to a similar magnitude as specific TH activity after
NGF treatment in 15- to 20-day cultures (Raynaud et al.
1988). TH mRNA levels start to increase at 12 h after NGF
addition and are NGF-concentration-dependent as analysed
after 5 days of culture (Ma et al. 1992). In vivo after NGF
injection into newborn rats from P2–P11, TH mRNA is
increased more than 10-fold as analysed by Northern blot
(Miller et al. 1991).
These studies show that NGF affects TH activity in
sympathetic ganglia in vivo and in vitro. This is achieved
by increased enzyme protein synthesis and enhanced steady
state mRNA levels but not increased transcription.
NT3 and NGF oppositely regulate cholinergic
and noradrenergic properties in vitro
In explants of sympathetic ganglia taken from E12 chick
and grown for 4 days in culture, NT3 promotes the
cholinergic markers ChAT and VIP but not the noradren-
ergic markers NET and TH as analysed by RT-PCR
(Brodski et al. 2002). NGF promotes the noradrenergic
but not the cholinergic markers. Results from the addition
of NT3 and NGF alternately suggests that the effects are not
attributable to selective survival but to alterations in mRNA
levels.
Thus, NTs might regulate the differentiation of neuro-
transmitter phenotype in vitro. In NT3 mutant mice,
however, the postnatal shift from noradrenergic to cholin-
ergic properties of sympathetic innervation to the sweat
glands appears to be unaffected, as revealed by IHC for
acetylcholinesterase and VIP (ElShamy et al. 1996).
Unfortunately, no data on the expression of ChAT in NT3
mutant mice at various developmental stages are available.
Summary
trk expression
The vast majority or even all mature sympathetic neurons
express the high-affinity NGF receptor trkA. A number of
studies from various mammalian species concur in showing
that trkC is expressed in only a small neuronal subpopu-
lation (10%–20%) in adult animals. trkB is found in a
negligible fraction of mature sympathetic neurons.
During mouse embryonic development, trkC is detect-
able at E11.5 in SCG and is expressed throughout the
ganglion at E13.5. Subsequently, trkC becomes restricted to
a small subpopulation detectable at birth. trkA expression in
mouse SCG is first found at E13.5 and increases to become
strong and widespread at birth. A similar sequence of trkA
and trkC expression is observed in sympathetic ganglia
during rat embryonic development. Likewise, in chick
embryos, trkC expression commences early and is down-
regulated in secondary sympathetic ganglia where trkA
becomes prominently expressed.
In chick embryos, coexpression of trkA and trkC
immunoreactivity is reported at early stages of sympathetic
neuron differentiation. Moreover, trkB and trkC immunor-
eactivities colocalize during early development but this is at
variance with ISH data for trkB. With ongoing develop-
ment, trkA and trkC expression segregate to different
neuron populations. Noradrenergic and cholinergic proper-
ties segregate with trkA and trkC expression, respectively,
in chick sympathetic ganglia.
Survival
Even though the onset of trkA and trkC expression differs
by 2 days in mouse embryonic development, the timing of
cell loss in NGF and NT3 mutant mice is similar and
becomes significant at E17.5. Moreover, no cell loss is
observed in trkC mutant mice suggesting NT3 action via
trkA. In trkA mutants, a small but significant cell loss is
reported even at E15.5; this may have been missed in the
NT mutants because of differences in the sampling method
and size.
The stringent requirement of NGF for survival persists
postnatally but is not apparent in mature animals. Although
embryonic and postnatal NGF depletion results in an
immediate loss of large numbers of sympathetic neurons,
short-term NGF depletion in adult rats leads to a reduction
in cell size, ganglion volume and protein content, whereas
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cell number appears unaffected. Only long-term NGF
deprivation for several weeks to months results in large-
scale cell loss.
Neurite outgrowth
The tight temporal correlation of cell death in NGF and
NT3 mutant animals suggests that the action of one factor
may not directly promote survival but provide access to the
other factor by stimulating neurite outgrowth. Indeed, NT3
is required for early neurite outgrowth even in the vicinity
of the SCG. NGF also promotes neurite extension but, at
later stages, close to the targets. Terminal sprouting appears
to be under NGF control.
Different from the effects of NT gene mutations on
sympathetic neuron numbers, the published effects on
neurite outgrowth differ clearly between animals and
laboratories. Whether this is attributable to specimen
selection or strain differences is unclear. It points, however,
to the crucial involvement of other factors in the regulation
of neurite access from ganglia to target.
Interestingly, the overexpression of NGF in epidermis
disrupts axon partitioning in the target by redirecting
sympathetic nerve fibres normally destined to innervate
sweat glands and blood vessels to alternate targets in the
dermis. This result shows that responsive neurites do not
simply project to the growth factor source in the
epidermis.
Formation of synaptic connections
NGF has the potential to affect the connectivity of
sympathetic neurons with preganglionic innervation and
with peripheral target tissues. NGF application in newborn
rats enhances dendritic growth and complexity and treat-
ment with anti-NGF antiserum in guinea-pigs at different
postnatal to adult stages reduces synapse density, presyn-
aptic area and the amplitude of postsynaptic potentials. The
studies show that NGF is required for the normal
development of synaptic connectivity between pregangli-
onic and postganglionic sympathetic neurons in vivo. A
molecular analysis of the underlying changes to reveal
whether the effect is presynaptic and/or postsynaptic would
greatly promote our understanding of NT actions.
In vitro studies indicate that NGF is also involved in the
development of target innervation. In coculture with
myocytes, NGF alters the effect of sympathetic neuron
stimulation on myocyte beat rate acutely and over extended
periods. Molecular evidence for the number of synaptic
sites suggests that synapse formation may be involved in
the process.
NGF, in collaboration with other in part uncharacterized
factors, shapes connectivity between preganglionic and
postganglionic sympathetic neurons and between postgan-
glionic sympathetic neurons and target cells.
Regulation of TH
NGF injection leads to a specific increase in TH activity in
sympathetic ganglia of rats and mice at all stages from
embryogenesis to adulthood. In vitro, the NGF-induced
increase in specific enzyme activity in sympathetic neurons
is attributable to increased protein synthesis. In spite of a
similar increase in TH mRNA levels after NGF treatment in
vitro, the increase in enzyme activity is not sensitive to
RNA synthesis blockers suggesting posttranscriptional
regulation. In PC12 cells, the NGF-induced increase in
TH mRNA levels has been shown to occur both posttran-
scriptionally and transcriptionally (Leonard et al. 1987;
Gizang-Ginsberg and Ziff 1990; Miller et al. 1991).
Together with the rapid activation of TH activity within
minutes of NGF administration by enzyme phosphorylation
in PC12 cells (Greene et al. 1984; McTigue et al. 1985),
NGF may engage a range of pathways to stimulate the
noradrenergic transmitter phenotype on different time
scales from minutes to days.
Transmitter phenotype
The induction of TH and NET mRNA by NGF and of
ChAT and VIP mRNA by NT3 in explants of sympathetic
ganglia from E12 chick strongly suggests a role of NT
signalling in the specification of sympathetic transmitter
phenotypes (Brodski et al. 2000). Importantly, the effect of
one factor can be reversed by the other factor, presumably
without major cell loss. This provokes the question as to
whether NTs specify early sympathetic neurons coexpress-
ing both noradrenergic and cholinergic properties to
develop into cells with only one or the other phenotype.
The postnatal shift in vivo from noradrenergic to choliner-
gic sympathetic innervation of sweat glands appears
unaffected by NT3 mutation (ElShamy et al. 1996) but
depends on gp130 signalling (Stanke et al. 2006). The
prenatal segregation of lineages in mouse after E13 is in
part ret-dependent (Burau et al. 2004). Contributions by trk
signalling to sympathetic transmitter specification in vivo
remain to be further analysed.
Regulation of ion channels
Potassium conductances, in particular calcium-dependent
potassium currents and M currents, contribute to the
diversity of the electrophysiological properties of sympa-
thetic neurons and appear differently expressed in neuronal
subpopulations (Jänig and McLachlan 1992). In vitro
studies in birds and mammals show that NGF affects these
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potassium conductances. A developmental analysis in vivo
of acute and long-term effects of NT signalling on
potassium conductances in avian and mammalian sympa-
thetic neurons is still missing.
Moreover, the regulation of calcium and sodium con-
ductances by NGF is of interest. In frog sympathetic
neurons, calcium conductances are sensitive to NGF levels
in vivo and the regulation of calcium and sodium currents
has been demonstrated in vitro. In rat PC12 cells, sodium
currents and various sodium channel transcripts are induced
by NGF (Mandel et al. 1988; D’Arcangelo et al. 1993).
Concluding remarks
trk expression and survival action of NTs
The developmental pattern of trk expression shows remark-
able similarities in the two neuronal lineages under
consideration. During DRG and sympathetic neuron devel-
opment, trkC is expressed before trkA and trkB. trkC is
initially expressed throughout the ganglia and then is
downregulated to a small subpopulation of neurons. trkB
and trkA become expressed later when the ganglionic cell
population is expanding.
In the chick embryo, the neurons initiating trkA and trkB
expression temporarily coexpress trkC. In the mouse embryo,
extensive overlap of trkB and trkC expression has been
reported during early phases of trkB expression in DRG
neurons. The segregation of trk expression to different
neuronal subpopulations becomes prominent only later.
The progressive embryonic restriction of trkC and trkB
expression in combination with the acquisition of trkA
expression in the majority of neurons leads to the formation
of subpopulations of sensory and autonomic neurons with
specific trk expression patterns and, as shown for DRG
neurons, distinct target tissues. In newborn mammals, the
large majority of DRG sensory neurons and sympathetic
autonomic neurons express trkA. Small proportions of
neurons express trkB and trkC. The ret-dependent postnatal
downregulation of trkA expression has been documented
for a population of DRG neurons.
Depletion by immunization or antibody injection dem-
onstrates the survival requirement for NGF of the vast
majority of sympathetic and DRG neurons during embry-
onic development, as has been confirmed in NGF and trkA
mutant mice. Whereas NGF dependence lasts into the
postnatal period for sympathetic neurons, DRG neurons
lose their NGF requirement for survival within the first few
postnatal days. In NGF and trkA mutant mice, cell death in
DRG precedes that in sympathetic ganglia. Cell loss
commences at the same developmental stage and affects
the same proportion of neurons in NGF and trkA mutants.
The situation is remarkably different for NT3 and trkC.
Mutation of trkC is without effect on sympathetic ganglion
cell numbers. NT3 mutants, on the other hand, show a
reduction in sympathetic neuron numbers with the same
time course as observed in NGF mutants. The data indicate
that NT3 is required for sympathetic fibre outgrowth to the
target tissues and access to NGF for survival. In DRG, both
NT3 and trkC are required for cell survival at an earlier
stage than NGF and trkA. With progressing development,
cell death in NT3 mutants exceeds that in trkC mutants
indicating a role for trkA in NT3 signal transduction. The
time course of the NT3 effect indicates a requirement for
DRG progenitors and differentiating neurons.
Developmental course of differentiation effects
Since rat DRG neurons lose their NGF dependence for
survival rapidly after birth, NGF-mediated differentiation
effects can be analysed in postnatal and adult animals after
the manipulation of NGF levels (Fig. 3a). Electrophysio-
logical analysis suggests a period of consolidation of
LTMR (D hair) versus HTMR fates during early postnatal
stages coincident with fibre rearrangement in the develop-
ing skin (Lewin and Mendell 1993). NGF deprivation
appears to shift Aδ HTMRs towards a D hair fate. In the C
fibre domain, mechanoheat-sensitive units appear to be
replaced by purely mechanosensitive afferents with an
altered threshold. At later stages, phenotypic expression of
specific properties remains subject to regulation by NGF
(Mendell 1996). Altered neuropeptide and ion channel
expression patterns in adult DRG neurons during inflam-
mation are mediated in part by elevated NGF levels.
The introduction of the NT/Bax double-mutant mice has
allowed NGF effects on differentiation to be analysed
embryonically. This has established the NGF requirement
for neuropeptide, ion channel and growth factor receptor
expression in prenatal DRG neurons (Fig. 3b). Culture
experiments indicate that the effects may occur directly on
the ganglionic cell population.
For sympathetic neurons, the regulation of TH by NGF
is shown from embryonic stages until adulthood. The
analysis of other properties of sympathetic neurons is less
complete and often restricted to cell culture.
Together, the data show that NT signalling, in particular
that of NGF, might regulate neuronal properties at all
developmental stages, uncorrelated with the survival re-
quirement for NGF.
NT effects on network differentiation and connectivity
For the sensory neurons in DRG, the available data indicate
that NT signalling affects a variety of differentiation events
crucial for integrating the developing cells in their sensory
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reflex networks. In the trkA-positive neuron population,
NGF and trkA signalling is required for the expression of
neuropeptides and GFL receptor subunits that specify
peptidergic and non-peptidergic nociceptor populations,
respectively. The expression of ion channels for the TRP
family, which are involved in heat and cold sensation by
small-diameter DRG neurons, is regulated by NGF/trkA
signalling at embryonic stages and in adult animals. In
addition, dorsal horn connectivity is affected by the
modulation of NGF levels in postnatal animals. Thus,
NGF/trkA signalling is essential for the molecular and
functional specification of small-diameter DRG neurons
and for their dorsal horn connectivity.
In the trkC-positive neuron population, the role of NT3
for the differentiation of proprioceptor properties is less
well characterized. The importance of target-derived NT3
for the projection of proprioceptors to their targets in the
ventral spinal cord and for functional transmission to
motoneurons, however, demonstrates the potency of NT3/
trkC signalling for the shaping of the monosynaptic
proprioceptor/motoneuron reflex pathway.
In sympathetic ganglia, NGF affects dendritic arboriza-
tion and synapse development of postganglionic neurons
and their connectivity with preganglionic neurons in vivo.
These observations warrant further molecular characteriza-
tion. Together with the in vivo data showing the require-
ment of NT3 and NGF for axonal projections and the in
vitro results suggesting an effect of NGF on target
innervation including synapse formation, the data indicate
that NTs act as signals that regulate neuronal differentiation
and the consequent integration into neural networks.
Signalling complexity
TH is regulated by NGF acutely via protein phosphoryla-
tion and in the long-term by protein synthesis. In
sympathetic ganglia, the NGF-induced increase in specific
TH activity is mediated by increased protein synthesis in
Fig. 3 NGF effects on proper-
ties of DRG neurons are ob-
served from embryogenesis to
adulthood. a The different peri-
ods of NGF sensitivity in noci-
ceptors and their precursors
before and after birth. Modified
from Lewin and Mendell 1993.
b Embryonic effects of NGF on
the expression of calcitonin-
gene related peptide (CGRP)
and substance P (SP) in Bax/
trkA double-mutants and of ret,
GFRalpha1, GFRalpha2,
TRPV1 and TRPM8 in Bax/
NGF double-mutants in vivo
and on neurons from Bax single
mutants in vitro (# number of
positive cells/section)
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parallel with increased mRNA amounts but, surprisingly,
might be transcription-independent. Thus, posttranscrip-
tional mechanisms appear active but these still have to be
characterized. Moreover, TRP channel regulation by NGF
in DRG occurs by both rapid and slow mechanisms. The
acute activation also involves protein phosphorylation. The
long-term regulation leads to increased mRNA levels that
are assumed to be transcription-dependent, although post-
transcriptional mechanisms cannot be excluded. Rapid
NGF-dependent increases of heat-sensitivity in mature,
but not postnatal, DRG neurons indicate that regulatory
mechanisms may show different developmental availability.
Despite the subpopulation-specific action of NTs, several
NTs might be involved in the development of a given neuron
subpopulation. NT3 is required for the generation of
approximately half of DRG and sympathetic neurons. In
DRG, not only proprioceptors are lost in NT3 mutant mice,
but also other sensory neuron populations (including pepti-
dergic nociceptors) are reduced in numbers. This nociceptor
population is reduced by ~50% in NT3 mutant animals and
appears to be completely eliminated by NGF mutation. The
precise interplay of NGF and NT3 signalling in nociceptor
development is not entirely clear. In sympathetic neurons,
NT3 promotes early neurite outgrowth and NGF regulates
later phases of neurite outgrowth, terminal branching and
neuron survival. DRG and sympathetic neurons differ,
however, in that cell loss attributable to the lack of NT3
appears as an indirect consequence of compromised access to
NGF sources in the target region of sympathetic neurons, but
not DRG. The molecular mechanisms underlying these
differences and also the prolonged postnatal requirement of
NGF for survival in sympathetic neurons as compared with
DRG remain to be analysed.
Another example of NT interaction is found in SAM
afferents, a population of LTMR. They require NT3 for
survival and BDNF for acquisition of mechanosensitive
properties. In the case of peptidergic nociceptors, NGF is
required for both survival and the acquisition of characteristic
neuronal properties. The molecular changes underlying the
shift from survival promotion to phenotype specification by
the same or different NTs still have to be determined.
In addition, NTs interact with other signalling systems.
Both NT and bone morphogenetic protein signalling appear
to be involved in dendrite formation of sympathetic
neurons. trk and ret signalling is required for the develop-
ment of non-peptidergic nociceptors in DRG. NGF signal-
ling via trkA promotes ret expression in a subpopulation of
DRG neurons. In sympathetic neurons, NGF stimulates ret
expression and, different from DRG, ret phosphorylation
(Tsui-Pierchala et al. 2002) adding another level of
signalling complexity. Deciphering the interplay of growth
factors in the regulation of the various aspects of neuronal
development will be an important task for future research.
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